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1 Summary 
DNA damage induced by various means can trigger mutagenesis and genome instability, 
if remained unrepaired. Especially bulky DNA lesions interfere with protein machineries 
that trek along the DNA. In contrast to DNA replication, the RNA transcription machinery is 
highly sensitive to such ‘road-blocks’ as translesion synthesis is rare. Upon stalling of the 
transcribing RNA polymerase II (RNAPII) in front of the DNA lesion, the lesion itself is 
often shielded by the RNAPII complex and is therefore inaccessible for repair. If the 
RNAPII complex cannot be dislodged from the lesion by backwards movement, the last 
option is complete removal of RNAPII from the chromatin to allow repair. Previous work 
showed that removal involves degradation of Rpb1, the largest subunit of RNAPII, which 
presumably triggers disassembly of the whole complex. Rpb1 is targeted by several 
enzymes and thereby becomes modified by ubiquitin and the small ubiquitin-like modifier 
(SUMO) in response to DNA damage. While ubiquitylation of Rpb1 was described to 
trigger proteasomal degradation, the fate of SUMOylated Rpb1 remained elusive.  
Taking advantage of different Rpb1 antibodies to study Rpb1 degradation upon 
DNA damage, it turned out that the elongating pool of Rpb1 is preferentially targeted for 
degradation. However, the previously identified ubiquitin ligases Rsp5 and Elc1-Cul3 do 
not contribute to ubiquitin-dependent degradation of elongating Rpb1 upon DNA damage. 
Instead, the stalled RNAPII complex is recognized by the SUMO machinery to target Rpb1 
and possibly other subunits for SUMOylation. SUMOylated Rpb1 might function as a 
recruiting factor to assemble remodeling factors like Rad26 and other proteins required for 
DNA repair. However, SUMOylated Rpb1 also recruits the so-called SUMO-targeted 
ubiquitin ligase (STUbL) Slx5/Slx8. Binding of Slx5/Slx8 to SUMOylated Rpb1 leads to 
subsequent polyubiquitylation. Rpb1, modified in this manner, is recognized by the 
ubiquitin/SUMO-selective segregase Cdc48. Finally, Cdc48 extracts Rpb1 from the 
chromatin-bound RNAPII complex and delivers it to the proteasome for degradation. 
 Although the mechanism proposed in this study is distinctly different from the 
previously identified Rpb1 degradation mechanism, it reveals striking parallels with the 
removal of other chromatin-bound proteins. 
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2 Introduction 
2.1 The Consequences of DNA Damage 
The genomic information stored in DNA is the basis for life and its faithful propagation to 
the next generation is essential for cell survival. To achieve this, the integrity of cellular 
processes like DNA replication, DNA transcription and RNA translation have to be 
maintained. However, cells are constantly challenged by exogenous stressors like 
ultraviolet (UV) light irradiation or alkylating agents, which can cause various forms of 
DNA damage. Additionally, endogenous metabolic compounds, like reactive oxygen 
species (ROS), can induce DNA breaks or base oxidations, which promote the formation 
of bulky lesions1. If DNA lesions are left unrepaired, they can interfere with crucial cellular 
processes. For instance, damaged DNA can block progression of the replicating or 
transcribing machineries, leading to persistent stalling on chromatin2. This in turn can 
trigger genomic instability, consequently leading to cancer or aging in multicellular 
organisms3. Therefore, all living cells have evolved repair mechanisms to deal with 
different forms of DNA damage and, via these mechanisms, aid in maintaining genomic 
stability1. In the course of this, repair of damaged DNA, which is occupied by a stalled 
protein complex, represents a special challenge for the cell. Not only does the damaged 
template DNA have to be recognized and repaired in a time-dependent manner, but also 
the cellular machineries for DNA and RNA synthesis must be maintained to some degree 
to allow potential restart after repair. Additionally, in the case of replication, the newly 
synthesized DNA must be preserved until the replication machinery can be restarted to 
prevent gross-chromosomal rearrangements4. Therefore, it is not surprising that DNA 
repair progression is tightly connected with protein remodeling, protein disassembly and 
protein turnover processes to get access to the damaged site and, whenever possible, to 
maintain the catalytic activity of stalled machineries.  
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2.2 DNA Repair in the Context of Stalled Replication Machinery 
The replication machinery, consisting of DNA polymerase and several auxiliary factors like 
the minichromosome maintenance (MCM) helicase complex and the proliferating cell 
nuclear antigen (PCNA), fulfills two functions – it replicates DNA and scans it for damaged 
sites simultaneously5-7. Stalling of the replicating DNA polymerase can occur at modified 
bases, single- and double-strand breaks, upon depletion of the nucleotide pool or at highly 
transcribed regions8. A stalled DNA polymerase can lead to the accumulation of single-
stranded DNA (ssDNA), because the replicative helicase proceeds with DNA unwinding 
while DNA synthesis is interrupted9. The replication protein A (RPA) subsequently binds 
the ssDNA and recruits the replication checkpoint kinase ATR (Mec1 in yeast). In contrast, 
stalled replication machinery at DNA double-strand breaks (DSBs) leads to the activation 
of the checkpoint kinase ATM (Tel1 in yeast). Phosphorylation of downstream targets by 
both checkpoint kinases results in p53-dependent cell cycle arrest and DNA repair by 
different mechanisms according to the nature of the DNA lesion4. Interestingly, the stalled 
replicative DNA polymerases are not removed, but remain bound to the DNA for 40-60 
minutes after DNA damage treatment in a replication competent state. Thus, the 
replication fork is stabilized and DNA replication can be potentially reactivated after repair 
completion10-12. 
To avoid potential cell cycle arrest upon stalling of the replication machinery, cells 
have evolved bypass mechanisms13. Upon replication stalling, the sliding clamp PCNA 
becomes modified by posttranslational modifications to govern the choice of bypass 
mechanism. Due to an uncoupling of DNA unwinding and DNA replication, accumulation 
of RPA-coated ssDNA triggers recruitment of the ubiquitin ligase Rad18 together with the 
ubiquitin-conjugating enzyme Rad614. This leads to monoubiquitylation of PCNA at lysine 
(K) 164, which in turn recruits the translesion synthesis (TLS) polymerases Polη, Polζ and 
Rev113. In contrast to the accurate replicative DNA polymerases, TLS polymerases have a 
larger active site and no proofreading mechanism, allowing accommodation of bulky 
lesions into their active center and incorporation of the correct or incorrect nucleotide 
opposite to the lesion15, therefore, this mechanism is error-prone. On the other hand, 
PCNA can also be modified with K63-linked polyubiquitin chains by the heterodimeric 
ubiquitin-conjugating enzyme Ubc13/Mms2 and the ubiquitin ligase Rad5, which promotes 
an error-free template switching mechanism16. For that, the information of the undamaged 
sister chromatid is used to replicate through the damaged template17. The precise 
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switching mechanism from replicative to translesion DNA polymerases is still unknown. A 
recent study proposed that proteasomal degradation of Pol3, the catalytic subunit of the 
replicative polymerase δ, is crucial to allow DNA binding by the TLS polymerase18.  
Interestingly, the prolonged stalled replication machinery itself can lead to DSB 
formation and subsequent repair by homologous recombination (HR). However, 
SUMOylated PCNA usually blocks unwanted sister chromatid recombination, which can 
lead to gross-chromosomal rearrangements. Usually, PCNA SUMOylation takes place 
under non-damage conditions and in turn recruits Srs2, an antirecombinogenic helicase, 
which disrupts Rad51 filaments and thereby inhibits HR13. 
 
 
2.3 DNA Repair in the Context of Stalled Transcription Machinery 
Transcribing RNA polymerases (RNAPs) are particularly susceptible to stalling at bulky 
DNA adducts. Exposure to UV light leads to the dimerization of adjacent pyrimidines 
resulting in cyclobutane pyrimidine dimers (CPDs) within the DNA. These CPDs, but not 
other bulky DNA lesions, can enter the active site of transcribing RNAPII and lead to 
stalling upon nucleotide misincorporation opposite to the lesion19. A prolonged stalled 
RNAPII can activate the checkpoint kinase ATR and, subsequently, trigger p53-dependent 
cell cycle arrest and DNA repair, similarly to a stalled replicative DNA polymerase20. In 
yeast, a special enzyme called photolyase removes CPDs in a light-dependent manner. 
Yet, CPD repair by photolyase is more efficient in the non-transcribed strand compared to 
the transcribed strand, indicating that the stalled RNAPII complex shields the CPD from 
recognition and repair21. A key mechanism to remove bulky DNA adducts, to avoid cell 
cycle arrest and cell death in yeast and higher organisms, is the nucleotide excision repair 
(NER) pathway22,23.  
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2.3.1 The Nucleotide Excision Repair (NER) Pathway 
Bulky DNA adducts, such as those caused by UV light, are preferentially repaired by the 
nucleotide excision repair (NER) pathway. Several syndromes are linked to mutations in 
NER genes. Among them are the genetic disorders Xeroderma Pigmentosum (XP)24, 
Cockayne syndrome (CS)25 and Trichothiodystrophy (TDD)26, which are associated with a 
predisposition towards cancer and accelerated aging.  
The NER pathway is initiated through lesion recognition, which differs in the two 
NER subpathways called global genome repair (GGR) and transcription-coupled repair 
(TCR). GGR removes DNA lesions genome wide, whereas TCR functions preferentially in 
the transcribed strand of actively transcribed genes (Figure 1).  
In the GGR pathway, lesion recognition is achieved through probing of the DNA for 
helix-distortions through the XPC-Rad23B-CETN2 complex (Rad4-Rad23 in yeast), which 
subsequently binds opposite to the lesion to ssDNA. This enables the GGR pathway to 
target a broad range of damage types27. Recognition is also possible through the UV-DDB 
complex, which binds directly to the UV light-induced lesion and stimulates recruitment of 
the XPC complex28. In turn, XPC binding stimulates recruitment of the transcription factor 
II H (TFIIH), which is a multi-subunit complex with DNA helicase activity29. The TFIIH 
helicase subunits XPB (Rad25) and XPD (Rad3) are implicated in DNA unwinding and 
damage detection30. Upon lesion detection, the damaged bases must be removed. Thus, 
XPA (Rad14), which is presumably recruited together with TFIIH, displaces the XPC 
complex and recruits the endonucleases XPF-ERCC1 (Rad1-Rad10) and XPG (Rad2). 
After dual incision from the 5’- and 3’-site, roughly 30 nucleotides, including the damaged 
bases, are removed. However, 5’-incision by XPF-ERCC1 is sufficient to initiate gap filling 
by DNA synthesis31. Binding of RPA to the undamaged ssDNA opposite to the lesion 
protects this part from cleavage by the endonucleases. Finally, depending on the cell 
cycle stage, DNA Polδ, Polε or Polκ fills the gap and DNA ligase 1 or 3 completes DNA 
repair32,33.  
The lesion recognition and verification steps differ in the two NER subpathways. In 
contrast to GGR, the TCR subpathway is activated through a prolonged stalled RNAPII 
complex and the DNA damage must be detected and subsequently repaired in the context 
of the stalled complex. Therefore, in humans, activation of the TCR pathway is controlled 
by the Cockayne syndrome (CS) proteins A and B, UV-stimulated scaffold protein A 
(UVSSA) and the ubiquitin-specific processing protease 7 (USP7), which transiently 
interact with the elongating RNAPII34,35. These factors recognize the stalled RNAPII 
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complex and are responsible for the recruitment of further TCR factors, which are 
important for DNA damage detection. In yeast, Rad26, the homolog of human CSB, and 
Rpb4/Rpb9, two non-essential subunits of RNAPII, are implicated in TCR activation36-39. 
Although CSB/Rad26 is crucial for TCR, it is still unclear how it recognizes stalled RNAPII. 
Data suggest that CSB/Rad26 travels with the elongating RNAPII and this interaction gets 
stabilized upon DNA damage40,41. Interestingly, Rad26, but apparently not CSB, becomes 
phosphorylated and is thereby activated upon DNA damage by the checkpoint kinase 
Mec142.  
Theoretically, once the DNA damage is detected in the TCR pathway the further 
repair steps, including DNA incision, gap filling and ligation, are identical for both NER 
pathways. However, the stalled RNAPII occupies roughly 35 nucleotides of the transcribed 
DNA strand and might hinder the endonucleases and other TCR factors to access the 
lesion43. There are three different possibilities of how the repair machinery can gain 
access to the lesion (Figure 1). First, the RNA polymerase can simply be released from 
the DNA to allow access. This has been shown to occur for RNAPII and RNAPI, but the 
underlying mechanism is poorly understood44,45. Second, RNAPII backtracking from the 
lesion can facilitate repair without dissociation. This is possible because RNAPII has a 
proofreading mechanism, which allows the complex to backtrack during transcription46-48. 
After RNAPII backtracking and successful DNA repair, reactivation of transcription 
requires RNA transcript cleavage for reposition of the 3’-end with the active center of 
RNAPII46,49. RNAPII itself possesses an internal RNA cleavage activity, which is required 
for this step. Moreover, reactivation of RNAPII is stimulated by the transcription factor II S 
(TFIIS), which is recruited in a CS-dependent manner in humans34. Interestingly, also 
RNAPII backtracking is thought to be activated by CSB50,51. Finally, as a last resort, 
RNAPII can be actively removed from the lesion by proteasomal degradation of its 
catalytic subunit Rpb152.  
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Figure 1: Removal of DNA lesions by the nucleotide excision repair (NER) pathway. 
DNA lesions throughout the genome are recognized and removed by the global genome repair (GGR) 
pathway. The lesion is detected through the XPC (Rad4) complex or the DDB1 complex. DNA lesions in the 
transcribed strand force RNA polymerase II (RNAPII) to halt. CSB (Rad26) recognizes the stalled RNAPII and 
activates the transcription-coupled repair (TCR) branch. To get access to the DNA damage site, RNAPII can 
be released, displaced by backwards movement or removed from chromatin. After DNA damage detection, 
both subpathways, TCR and GGR, converge to the following NER steps. The transcription factor II H (TFIIH) 
is recruited to DNA lesion sites. This multi-subunit complex contains the helicases XPB (Rad25) and XPD 
(Rad3) to allow DNA unwinding. XPA (Rad14) and RPA have lesion detection functions. RPA binds to the 
undamaged ssDNA to avoid unwanted endonuclease cleavage. XPF1-ERCC1 (Rad1-Rad10) incises at the 5’-
site, whereas XPG (Rad2) acts on the 3’-site. Roughly 30 nucleotides are removed by dual incision, whereas 
5’-site incision is enough to start gap filling by DNA polymerases. The repair process is completed after strand 
ligation.  
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2.4 Degradation of RNA Polymerase II upon DNA Damage 
In order to get access to DNA lesions, which are occupied by an irreversibly stalled 
RNAPII complex, the last resort is to remove RNAPII from chromatin. This is achieved 
through turnover of its catalytic subunit Rpb1, whereas other subunits are not affected53. 
Over the last decades, a multistep mechanism has been described in yeast and humans, 
including ubiquitylation of Rpb1 to induce proteasomal degradation52. Additionally, Rpb1 is 
targeted for other posttranslational modifications under DNA damage conditions as well as 
during the transcription cycle. In the following, general posttranslational modifications of 
Rpb1 will be described first. Next, specifically the posttranslational modifications by 
ubiquitin and the small ubiquitin-like modifier (SUMO) will be explained more in detail, 
since they are of special interest for this work. Finally, the DNA damage-triggered Rpb1 
degradation pathway will be introduced.  
 
 
2.4.1 Posttranslational Modifications of Rpb1 
RNA polymerase II is a 12-subunit complex important for transcription of protein-coding 
genes, as well as for synthesis of non-coding RNAs54-56. To ensure efficient and faithful 
transcription, the largest subunit, Rpb1, is targeted for diverse posttranslational 
modifications. These modifications influence the recruitment of binding partners to 
catalyze and synchronize transcription progression with mRNA processing57. The main 
target for posttranslational modifications throughout the transcription cycle is the carboxy-
terminal domain (CTD) of Rpb1 (Figure 2).  
The CTD consists of repeating peptides of the consensus sequence Tyr1-Ser2-
Pro3-Thr4-Ser5-Pro6-Ser7. The number of repeats is species-dependent, with 26 copies in 
S. cerevisiae and 52 repeats in humans. However, not every repeat follows the consensus 
sequence58,59. Moreover, not every repeat within the CTD is equally modified at any given 
time60,61. The CTD can be targeted for acetylation, glycosylation, proline cis/trans 
isomerization, methylation, phosphorylation and ubiquitylation59. The phosphorylation 
pattern at serine (Ser) 2 and Ser5 has been extensively studied and is probably the most 
well-understood Rpb1 modification. 
Rpb1 is phosphorylated at Ser5 by Kin28 (CDK7 in humans), which belongs to the 
TFIIH complex62. In contrast, Ser2 is targeted by two different kinases, Bur1 (CDK9 in 
humans) and the CTDK1 complex63. Both belong to the cyclin-dependent kinase family. 
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However, Srb10 (CDK8 in humans) can also phosphorylate Ser5 and Ser2 in vitro62,64. 
The phosphorylation patterns at Ser5 or Ser2 follow opposite trends. When Rpb1 is bound 
to the promoter and the 5’-region of genes, it is preferentially phosphorylated at Ser5. 
However, when RNA polymerase travels through the gene body, this modification on 
Rpb1 declines due to the activity of the phosphatases Ssu72 and Rtr165,66. In contrast, 
Ser2 phosphorylation is associated with transcription elongation and levels increase 
towards the 3’-region of the gene and then decrease beyond the polyA site61. After 
transcription termination, the phosphatase Fcp1 removes residual phosphorylations67-69. 
 
 
 
Figure 2: Posttranslational modifications of Rpb1.  
Rpb1 can be modified at different regions. The enzymes involved are color-coded according to the 
modification. The consensus sequence of the C-terminal domain (proximal part) is targeted by 
phosphorylation (P) at serine 5 (S5) and serine 2 (S2) during transcription, whereas dephosphorylation is 
important to proceed in the transcription cycle. Cis/trans isomerization between proline 3 (P3) and proline 6 
(P6) controls binding of proteins for transcription progression. Ubiquitylation (Ub) can take place at the 7th 
residue (N7) of non-consensus sequences (distal part) in humans or at the very C-terminus (CTD tip), 
observed in yeast cells. Ubiquitylation in the catalytic core region is thought to induce proteasomal 
degradation of Rpb1. 
 
 
Although the CTD consensus sequence lacks lysine residues, the tail can be 
ubiquitylated at non-consensus sites58 (Figure 2, CTD distal part). In humans, the ubiquitin 
ligase Wwp2 ubiquitylates the CTD of Rpb1 and triggers proteasomal degradation in a 
DNA damage-independent manner70. This is thought to be a mechanism to regulate Rpb1 
levels. In yeast, two ubiquitylation sites in the CTD tip region were identified, which are 
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targeted by the ubiquitin ligase Asr171. However, Rpb1 remained extensively ubiquitylated 
upon Asr1 deletion, arguing for a redundant ubiquitin ligase for these sites. 
Simultaneously, the RNAPII subunit Rpb2 is ubiquitylated by Asr1 as well. 
Monoubiquitylation of Rpb1 and Rpb2 by Asr1 triggers removal of the RNAPII subunits 
Rpb4 and Rpb7 from the complex. Since Asr1 targets Rpb1, which is phosphorylated at 
Ser5, it was suggested that monoubiquitylation by Asr1 triggers RNAPII complex 
disassembly after abortive and cryptic transcription events71.  
Apart from the above-mentioned CTD modifications, other lysine residues in the 
catalytic core region are targeted for ubiquitylation to trigger proteasomal degradation 
(described in section 2.4.4 in more detail). In addition, the catalytic core domain is also 
targeted for SUMOylation by the SUMO ligase Siz1 together with the SUMO-conjugating 
enzyme Ubc972. SUMOylation of Rpb1 is induced upon DNA damage or transcriptional 
impairment, but has not been linked to Rpb1 ubiquitylation or proteasomal degradation so 
far. Instead, this modification is thought to restrain the DNA damage checkpoint response 
induced by a stalled RNAPII complex72. 
 
 
2.4.2 Ubiquitin and the Small Ubiquitin-Like Modifier (SUMO)  
Ubiquitin (Ub) and other ubiquitin-like modifiers are covalently conjugated to substrate 
proteins and thereby affect their activity, localization, folding or stability73. The small 
ubiquitin-like modifier (SUMO) shares several similarities with ubiquitin (Figure 3). It is 
transcribed as an inactive precursor and needs proteolytic cleavage to expose a C-
terminal double glycine motif that is required for conjugation74. Similar to ubiquitin, the 
attachment of SUMO to substrates requires the action of three enzymes. The activating 
enzyme (also called E1) forms a thioester bond with the C-terminal carboxy group of 
Ub/SUMO in an ATP-dependent manner. Next, Ub/SUMO is transferred to the catalytic 
cysteine of the conjugating enzyme (E2) by transesterification. Finally, Ub/SUMO is 
transferred to a lysine within the substrate protein forming an isopeptide bond with its C-
terminal glycine residue. The last step is usually facilitated by Ub/SUMO ligases (E3)75.  
While 11 ubiquitin E2s and 60-100 of ubiquitin E3 enzymes mediate ubiquitylation 
in yeast, only one SUMO E2 (Ubc9) and four SUMO E3 enzymes (Siz1, Siz2, Mms21 and 
Zip3) have been identified76. Substrate specificity in the ubiquitin pathway is achieved 
through enzyme diversification, while in the case of SUMO distinct cellular localizations of 
the conjugating enzymes are thought to provide specificity to the SUMO system77,78.  
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Figure 3: The ubiquitin and SUMO conjugation and deconjugation system.  
Ubiquitin (Ub) and the small ubiquitin-like modifier (SUMO) (S) are synthesized as inactive precursors with a 
C-terminal extension (X). Proteolytic cleavage results in the exposure of the C-terminal double glycine motif 
(GG). Conjugation of both modifiers to substrate proteins (Sub) implies the action of three enzymes. First, the 
activating enzyme (E1) forms a thioester bond with the C-terminus of the modifier in an ATP-dependent 
manner. Second, the modifier is transferred to a cysteine of the conjugating enzyme (E2). Finally the ligase 
(E3) promotes E2-substrate interaction and facilitates the binding of the modifier to an internal lysine (K) 
residue of the substrate. However, special ubiquitin ligases can also form a thioester bond with ubiquitin 
before ubiquitin is transferred to the substrate. To assemble polyubiquitin/SUMO chains, several conjugation 
rounds are necessary. Ubiquitin/SUMO-attachment is a reversible process and can be reserved by 
isopeptidases, which hydrolyze the peptide bond between the modifier and the substrate.  
 
 
Attachment of Ub/SUMO is a reversible process. While several ubiquitin-specific 
proteases (UBPs) hydrolyze the peptide bond between ubiquitin and substrate proteins, 
only two SUMO isopeptidases, Ulp1 and Ulp2, reverse SUMO modifications. Moreover, 
Ulp1 is also required for SUMO maturation at the nuclear envelope79.  
Substrate proteins can be modified by a single Ub/SUMO entity at individual or 
several different lysine residues, termed mono- and multiubiquitylation/SUMOylation, 
respectively. However, Ub/SUMO can also be attached to lysine residues on ubiquitin or 
SUMO, resulting in chain formation (polyubiquitylation/SUMOylation). All seven internal 
lysines of ubiquitin (K6, K11, K27, K29, K33, K48 and K63) are used for chain formation in 
vivo80. These ubiquitin polymers can be composed of a single or mixed linkage types, 
resulting in homotypic/heterotypic or even branched chains. Mono/polyubiquitylated 
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substrates are subsequently recognized by partner proteins harboring ubiquitin-binding 
domains (UBDs) or by specific ubiquitin receptors81-83. The yeast SUMO protein (encoded 
by a single gene SMT3) harbors nine lysines (K11, K15, K19, K27, K38, K40, K41, K54, 
K58), however, only the first three are efficiently used for chain formation84,85. While 
multiple UBDs exist, SUMOylated proteins are recognized by a short stretch of 
hydrophobic amino acids termed SUMO-interacting motif (SIM). These motifs have been 
found in a variety of proteins, including SUMO ligases, SUMO-targeted ubiquitin ligases 
and other SUMO-binding proteins86. 
 
 
2.4.3 Functions of Ubiquitylation and SUMOylation 
Covalent attachment of ubiquitin to substrate proteins can have proteolytic or non-
proteolytic outcomes. Best studied is the proteolytic degradation of preferentially 
polyubiquitylated proteins by the 26S proteasome.  
The proteasome is a multi-subunit protease complex consisting of a 20S core 
particle and a 19S regulatory particle87. Proteolytic cleavage is performed in the cavity of 
the 20S particle, which exhibits a barrel-like structure. The 19S unit is located at each end 
of the 20S particle. The 19S particle mediates substrate recognition, protein unfolding, 
deubiquitylation and entry into the 20S particle in an ATP-dependent manner88. While 
attachment of a single ubiquitin moiety in most cases is insufficient, preferentially K48- 
and K29-linked polyubiquitin chains target proteins to the proteasome, although 
exceptions are known89-91. Protein degradation by the proteasome is important for several 
cellular pathways, among them protein quality control, cell cycle regulation or antigen 
production for MHC recognition92. Moreover, non-proteolytic functions of ubiquitin are 
implicated in DNA repair (see above section 2.2), gene transcription, endocytosis, protein-
protein interaction, enzyme activation and cell signaling93-96. 
Most known SUMOylated substrates are located in the nucleus and are implicated 
in DNA repair, gene transcription, replication or chromatin organization97,98, but cytosolic, 
mitochondrial, plasma membrane- or ER-bound proteins can be SUMOylated as well75. 
The attachment of SUMO can influence stability, folding, activity, localization or protein-
protein interaction properties of the substrate protein99. However, the underlying molecular 
consequences are diverse. SUMOylation can prevent other posttranslational 
modifications, like ubiquitylation, by competing for the same acceptor lysine. In addition, 
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the newly attached binding surface of SUMO itself can inhibit or foster protein-protein 
interactions77. SUMOylation frequently targets multi-subunit complexes or protein groups 
that act in the same pathway. This so-called ‘protein-group SUMOylation’ takes place 
upon heat-shock or DNA damage induction78,100. Protein-group SUMOylation might 
provide protein complex stability mediated by SUMO-SIM interactions, thereby enhancing 
its activity.  
There are two different fates for SUMO-modified proteins. First, modified proteins 
can be deSUMOylated and recycled to the non-modified state. Second, SUMOylated 
proteins can be further modified with ubiquitin by SUMO-targeted ubiquitin ligases 
(STUbLs), which can subsequently trigger proteasomal degradation77,101. This special 
class of enzymes provides an important link between the SUMO and the ubiquitin system 
and will be described later in section 2.4.5 more precisely.  
 
 
2.4.4 Mechanism of Proteasomal Degradation of Rpb1 
The sequential action of different enzymes on Rpb1 upon DNA damage is illustrated in 
Figure 4. First, the ubiquitin ligase Rsp5 was implicated in Rpb1 turnover102-106. In vitro 
studies revealed that Rsp5 binds the carboxy-terminal domain (CTD) of Rpb1 via the WW 
domain and is able to monoubiquitylate Rpb1 in a DNA damage-independent manner. 
Based on in vitro studies it was proposed that Rsp5 together with the ubiquitin-conjugating 
enzymes Ubc4/Ubc5 attaches K63-linked polyubiquitin chains to Rpb1107. However, Rpb1 
modified by K63 chains is not targeted for degradation but is rather a substrate of the 
ubiquitin protease Ubp2107-109. Ubp2 hydrolyzes the K63-linked chains resulting again in 
monoubiquitylated Rpb1. It was proposed that this might be a proofreading mechanism to 
avoid premature Rpb1 proteolysis. To trigger turnover, monoubiquitylated Rpb1 is 
targeted by a cullin-based ubiquitin ligase complex, composed of Elc1, Ela1, Cul3 and 
Roc1. In vitro studies revealed that this ligase adds K48-linked chains to 
monoubiquitylated Rpb1107. Deletion of the non-essential subunits Elc1, Ela1 or Cul3 
results in a delay in Rpb1 turnover after DNA damage110,111. However, whether the present 
monoubiquitin is extended or whether the Elc1-Cul3 complex targets another lysine within 
Rpb1 is unclear. Two lysine residues (K330 and K695) within Rpb1 were identified to be 
modified by Rsp5112. DNA damage-induced ubiquitylation was highly reduced upon 
mutation of the coding sequences for both lysines. However, mutation of the coding 
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sequence of K330 alone was suggested to abolish Rpb1 degradation. Moreover, crystal-
structure analysis of RNAPII demonstrated that K695 lies in a region where the non-
essential subunit Rpb9 binds Rpb1112,113. However, to avoid degradation, Rpb1 modified 
by K48-linked ubiquitin chains can be rescued by deubiquitylation mediated by the 
ubiquitin protease Ubp3114. Finally, clearance of polyubiquitylated Rpb1 from the DNA is 
dependent on the ATPase Cdc48115. Cdc48 together with the adaptor proteins Ubx4/Ubx5 
mediates extraction of Rpb1 from the chromatin-bound RNAPII complex for subsequent 
delivery to the proteasome for degradation115,116. Recently, the chromatin remodeling 
complex INO80 has been implicated in Cdc48 binding. It was suggested that INO80 
facilitates degradation of chromatin-bound Rpb1 through nucleosome remodeling117. 
In human cells, Nedd4, the human homolog of Rsp5, binds and monoubiquitylates 
Rpb1 in vitro105,118. This monoubiquitylation is thought to be important to trigger 
polyubiquitylation by the Elongin A/B/C ligase, which is the human homolog of yeast 
Elc1/Ela1, suggesting that this is a evolutionary conserved mechanism119. However, Rsp5 
preferentially binds Rpb1 phosphorylated at Ser2 on the CTD. Further, Rsp5 binding is 
blocked if Rpb1 is phosphorylated at Ser5103,120. In contrast, Elongin A/B/C binds 
preferentially Ser5 phosphorylated Rpb1119.  
Moreover, although CSB and Rad26 both contribute to TCR, they have seemingly 
opposite effects on Rpb1 stability comparing yeast with human cells. While Rad26 has 
been described to counteract Rpb1 degradation, CSB induces Rpb1 turnover upon DNA 
damage121-123.  
Additionally, Rad26 interacts with the degradation factor 1 (Def1), which cycles 
between the nucleus and the cytoplasm121. Upon DNA damage, Def1 has been suggested 
to be monoubiquitylated by Rsp5 and cleaved by the proteasome. The processed version 
is retained in the nucleus and mediates binding between the Elc1-Cul3 ligase and Rpb1 to 
support its degradation120,124. Rad26 has been proposed to antagonize Def1 function to 
allow repair by the TCR machinery without the necessity to remove RNAPII. However, the 
underlying mechanism is unclear and recent data contradict this model125. Interestingly 
CSB, but not Rad26, is targeted for degradation in a CSA and Cdc48-dependent manner 
upon UV light irradiation122,126. 
Taken together, Rpb1 seems to be targeted for proteasomal degradation after DNA 
damage to allow DNA damage repair. However, several ubiquitin ligases also target Rpb1 
in a DNA damage-independent manner and their functions on Rpb1 were previously 
analyzed by in vitro studies. Further, Rsp5 acts also on other proteins implicated in Rpb1 
Introduction 
	 15 
degradation. This makes a conclusive interpretation of data difficult, as indirect effects 
cannot be ruled out. Since Rpb1 is also SUMOylated upon DNA damage, it remains a 
possibility that it is a substrate for the so-called SUMO-targeted ubiquitin ligases.  
 
 
 
 
Figure 4: Targeting of stalled RNA polymerase II for proteasomal degradation. 
RNA polymerase II (RNAPII) stalls at DNA lesions and is targeted for removal to allow lesion repair. The 
largest subunit, Rpb1, is first monoubiquitylated (Ub) by the ubiquitin ligase Rsp5, which can further attach 
K63-linked ubiquitin chains (right part). This is thought to be a protein quality control mechanism to avoid 
unwanted Rpb1 degradation and can be reversed by the deubiquitylation enzyme Ubp2. Ubp2 trims K63-
linked chains resulting in monoubiquitylated Rpb1. To trigger degradation, the ubiquitin ligase complex Elc1-
Cul3 attaches K48-linked chains (left part). This triggers recruitment of the segregase Cdc48 to deliver 
polyubiquitylated Rpb1 to the proteasome for degradation. Consequently, it is thought that the RNAPII 
complex will disassemble and liberate the DNA for repair. However, Ubp3 can rescue Rpb1 from degradation 
by complete hydrolysis of the ubiquitin chain. 
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2.4.5 SUMO-Targeted Ubiquitin Ligases (STUbLs) 
SUMO-targeted ubiquitin ligases (STUbLs) harbor several SUMO-interacting motifs 
(SIMs), which allow the enzyme to recognize and bind SUMOylated proteins (Figure 5). 
Attachment of polyubiquitin chains to the SUMOylated substrates typically leads to 
proteasomal degradation127. So far, several enzymes were shown to function as STUbLs. 
All of them are RING domain ubiquitin ligases possessing several SIMs. RING-type 
ubiquitin ligases facilitate the transfer of ubiquitin to its substrate protein by bringing the 
substrate protein and the E2-ubiquitin intermediate in close proximity128.  
In yeast, the ubiquitin ligase and DNA-dependent ATPase Ris1 was shown to 
promote degradation of certain SUMOylated proteins129. These proteins were implicated in 
mating type silencing, replication stress response, inhibition of non-homologous end-
joining of telomeres and chromosome segregation130-134.  
The heterodimer Slx5/Slx8 is another STUbL, which shares sequence homology 
with STUbLs from fission yeast and humans. Both, Slx5 and Slx8, have a C-terminal 
RING domain and Slx5 additionally harbors multiple SIMs while Slx8 has a DNA-binding 
domain and a putative SIM. Data suggest that Slx5 is important for recognition of the 
substrate, which is subsequently ubiquitylated by Slx8135,136. However, substrate 
SUMOylation is not a strict prerequisite to recruit Slx5/Slx8 since other structural features 
might also be recognized134,136. Moreover, after recruitment of Slx5/Slx8, other adjacent 
proteins can also be ubiquitylated in trans134. Recently, Slx5/Slx8 was shown to function in 
DSB repair at the nuclear periphery137,138. Binding of the DSB to the nuclear pore complex 
(NPC) is thought to be mediated through Slx5/Slx8, which binds the nuclear pore protein 
Nup84 but also the damaged DNA. However, the underlying mechanism is unclear. It was 
proposed that a SUMOylated protein might accumulate at collapsed forks and appropriate 
repair requires Slx5/Slx8-dependent ubiquitylation and proteasomal degradation of this 
substrate137,138.  
Similar to budding yeast Slx5/Slx8, also the fission yeast STUbL Slx8/Rfp1/Rfp2 
and the human homolog RNF4 function in genome stability and DNA repair137,139-141. 
Intriguingly, RNF4 may also play a non-proteolytic role in DNA damage response, as it 
catalyzes K63-linked polyubiquitin chains. Further, RNF4 is recruited to promyelocytic 
leukaemia (PML) bodies. Induced by arsenic, RNF4 targets SUMOylated PML proteins for 
ubiquitylation and subsequent proteasomal degradation, which in turn leads to the 
disassembly of PML bodies142,143. Interestingly, a non-proteolytic function was also 
suggested for the human STUbL RNF111, which targets SUMOylated XPC to attach K63-
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linked ubiquitin chains144-146. XPC, which functions in the nucleotide excision repair 
pathway, gets SUMOylated upon UV light treatment. Subsequently, RNF11-dependent 
ubiquitylation triggers dissociation of XPC from the DNA to promote DNA lesion repair. 
However, XPC is not targeted for degradation but rather gets recycled by 
deubiquitylation147,148.  
Recently, the ubiquitin ligase Rad18 has been suggested to belong to the STUbL 
family as well. Rad18 is recruited to SUMOylated PCNA and governs translesion 
synthesis during replication stress16,149 (see above section 2.2).  
 
 
 
 
 
Figure 5: Model for the action of SUMO-targeted ubiquitin ligases (STUbLs). 
SUMOylated (S) substrates (Sub) are recognized by multiple SUMO-interacting motifs (SIMs) of the STUbLs. 
In most cases, the RING domain containing STUbL (like Slx5/Slx8) promotes attachment of ubiquitin (Ub) 
moieties by facilitating the interaction between the ubiquitin-conjugating enzyme (E2) and the substrate. 
Ubiquitin can be attached either to the preexisting SUMO chain or to a lysine (K) within the substrate. Usually, 
the (poly)ubiquitylated substrates are targeted for proteasomal degradation.  
 
 
 
The conserved AAA-type ATPase Cdc48 (p97 in humans) typically targets 
ubiquitylated proteins, but also participates in the SUMO pathway150. Cdc48 uses ATP 
hydrolysis to segregate these substrates from their cellular compartment such as 
chromatin, cellular membranes or protein complexes151. The fate of the segregated 
proteins is further determined by so-called substrate processing co-factors150. Usually, 
proteins bound to Cdc48 are delivered for proteasomal degradation115,152. Since Cdc48 
also targets SUMOylated proteins and associates with a number of ubiquitin ligases, it 
was considered to be a multi-subunit STUbL77,153,154. 
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3 Aims of this Study 
Rpb1, the largest subunit of RNA polymerase II, is targeted for proteasomal degradation 
upon DNA damage. Rpb1 degradation seems to be important to remove DNA damage-
stalled RNAPII complexes from chromatin to allow for DNA repair52. The model proposed 
so far is highly complicated and implicates ubiquitylation of Rpb1 by two distinct ubiquitin 
ligases acting in a sequential mode107.  
 However, initial experiments in our laboratory failed to reproduce the phenotype of 
Rpb1 degradation upon DNA damage using the same setup described by other groups121. 
Only when we used an antibody recognizing the elongating pool of RNAPII we were able 
to reproduce Rpb1 turnover in WT cells. We also found that the so far described ubiquitin 
ligases are not implicated in Rpb1 degradation.  
Using our experimental setup, we aimed to elucidate the mechanism by which 
elongating RNAPII is degraded and which enzymes are involved in this pathway. 
Moreover, it was suggested that DNA damage not only triggers Rpb1 ubiquitylation but 
also Rpb1 SUMOylation72. However, so far the fate of SUMOylated Rpb1 was enigmatic. 
Another aim was therefore to elucidate how the posttranslational modification SUMO 
contributes to Rpb1 regulation upon DNA damage.  
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4 Results 
4.1 DNA damage-induced degradation of Rpb1 from the elongating pool of 
RNA polymerase II 
To monitor degradation after DNA damage induction, Rpb1 protein levels can be detected 
using several commercially available antibodies. Most of them are raised against the 
carboxy-terminal domain (CTD) of Rpb1, which is targeted for posttranslational 
modifications during the transcriptional cycle59. However, using antibodies which 
recognize specific modifications of the CTD of Rpb1, one can distinguish between RNAPII 
complexes at different transcriptional stages.  
To monitor Rpb1 turnover, cells were irradiated with UV light followed by a 
recovery phase. After irradiation, cells were kept in the dark to avoid DNA repair by the 
light-activated enzyme photolyase, thereby triggering transcriptional stalling. The Rpb1 
protein levels were measured after various recovery time points. For western blot (WB) 
analysis we compared antibodies recognizing distinct pools of RNAPII. The monoclonal 
antibodies 4H8 and 8WG16 preferentially recognize the unmodified CTD of Rpb1 and 
therefore detect the whole pool of RNAPII, chromatin-bound or -unbound. Moreover, we 
also used antibodies recognizing the CTD phosphorylated on the serine at position two 
(S2P), characterizing the elongating pool of RNAPII, or position five (S5P), marking the 
transcription initiating pool of RNAPII. In contrast to previous work we observed almost no 
turnover of Rpb1 using antibodies recognizing the whole pool of RNAPII (Figure 6, 
8WG16 and 4H8). However, we were able to detected robust Rpb1 turnover when we 
monitored Rpb1 with the S2P-specific antibody, which recognizes Rpb1 actively 
transcribing DNA. Surprisingly, Rpb1 turnover seemed to be highly specific for this 
elongating pool, since the transcription initiating pool of RNAPII was not affected by DNA 
damage-induced degradation (Figure 6, S5P).  
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Figure 6: Rpb1 is degraded preferentially from the elongating pool of RNAPII upon DNA damage. 
Rpb1 protein levels after UV light treatment (400 J/m2) followed by a recovery phase of 4 hours in YPD 
medium. For the recovery phase cells were kept in the dark. For the western blots (WB) antibodies (AB) 
against the C-terminal domain (CTD) of Rpb1 were used. The S2P- or S5P-specific antibody recognizes 
phosphorylated serine-2 or serine-5 in the CTD of Rpb1, 8WG16 and 4H8 recognize the CTD independent of 
any modification. Dpm1 served as loading control.  
 
 
To exclude that turnover of Rpb1 was masked by newly translated Rpb1, we also 
monitored Rpb1 levels after UV light in the presence of the protein synthesis inhibitor 
cycloheximide (CHX) (Figure 7A). Again, we hardly detected any decay in Rpb1 levels 
using the whole pool antibody 8WG16, but with the S2P-specific antibody (Figure 7A, 
compare upper and lower panel CHX+UV). Note that Rpb1 turnover was substantially 
lower in UV light-unchallenged cells (Figure 7A, CHX). Besides UV light irradiation we also 
introduced DNA lesions using the mutagenic compound 4-nitroquinoline 1-oxide (4NQO). 
4NQO was described to induce DNA damage through reactive oxygen species and to 
activate the same repair mechanism as UV light treatment155. Independent of the DNA 
damage source, UV light or 4NQO, Rpb1 was preferentially degraded from the elongating 
pool of RNAPII in various different yeast backgrounds (Figure 7B and Figure 7C). This 
further strengthens the fact that the preferential degradation of the elongating pool of 
RNAPII reflects a common mechanism upon DNA damage. 
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Figure 7: Rpb1 is degraded from the elongating pool of RNAPII independent of the DNA damage 
source or the yeast background. 
(A) Rpb1 protein levels in untreated (CHX) or UV light-treated (CHX+UV) (400 J/m2) WT cells followed by a 
recovery phase in YPD supplemented with cycloheximide (CHX) (100 µg/ml). For the WB the S2P-specific 
and the 8WG16 antibodies were used to detect Rpb1. Dpm1 served as loading control. 
(B) Rpb1 protein levels after 4-nitroquinoline 1-oxide (4NQO) (10 µg/ml) treatment in different yeast 
background WT cells (DF5 and W303) followed by a recovery phase in YPD medium. Rpb1 was detected with 
the 8WG16 or S2P-specific antibody. Dpm1 served as loading control. 
(C) Rpb1 protein levels in different yeast background WT cells (DF5, W303 and BY4741) after UV light 
treatment (400 J/m2) followed by a recovery phase of 4 hours in YPD medium. Rpb1 was detected using the 
S2P-specific antibody. Dpm1 served as loading control. 
 
 
 
 
A
anti-Rpb1 (8WG16)250kDa –
Recovery [h]: 
anti-Dpm1
- 1 2 3 4.5
CHX 
- 1 2 3 4.5
CHX + UV 
250kDa – anti-Rpb1 (S2P)
anti-Dpm1
Treatment: 
C
After UV [h]: - 1 2 3 4.5
DF5
- 1 2 3 4.5
BY4741
- 1 2 3 4.5
W303
anti-Rpb1 (S2P)
anti-Dpm1
Strain background:
B
- 1 2 4After 4NQO [h]: 
anti-Rpb1 (4H8)
anti-Dpm1
250kDa –
250kDa –
- 1 2 4
anti-Rpb1 (S2P)
anti-Dpm1
DF5 W303Strain background:
Results 
	
	 22 
4.2 Degradation of Rpb1 is dependent on the proteasome and the 
ubiquitin/SUMO-specific segregase Cdc48 
It was described previously that turnover of Rpb1 upon stalling at DNA lesion sites relies 
on the ubiquitin proteasome system (UPS) and the ubiquitin/SUMO-specific segregase 
Cdc48115. To confirm this involvement also for the elongating pool of Rpb1, we followed 
Rpb1 levels after UV light irradiation using the S2P-specific antibody. In agreement with 
previous work, we noticed Rpb1 accumulation in mutants defective in proteasome activity 
(Figure 8A, hypomorphic mutant cim3-1) or in the ubiquitin/SUMO-specific segregase 
Cdc48 (Figure 8B, hypomorphic mutants cdc48-6 and cdc48-3).  
Given that (poly)ubiquitylated substrates are often targeted for proteasomal 
degradation, we wondered whether polyubiquitylated species of Rpb1 could be detected 
after DNA damage induction. To test this, we immunoprecipitated Rpb1 from UV light-
treated (+) and -untreated (–) cells using the S2P-specific antibody and analyzed the 
samples by western blotting. Indeed, Rpb1 immunoprecipitated from UV light-treated cells 
was cross-reactive with a ubiquitin-specific antibody (Ub) (Figure 8C, WT). Considering 
that attachment of polyubiquitin chains to a substrate protein results in various slower-
migrating species, the here-detected Rpb1 was rather monoubiquitylated than 
polyubiquitylated. Moreover, this pool of ubiquitylated Rpb1 was not enriched in Cdc48 
mutant cells after UV light treatment (Figure 8C, cdc48-6). Presumably, Cdc48 does not 
target the identified monoubiquitylated pool of Rpb1.  
Usually polyubiquitylated species are difficult to detect because the conjugates are 
subsequently degraded by the proteasome. Therefore, we used the hypomorphic 
proteasome mutant cim3-1 to prolong the half-life of polyubiquitylated Rpb1 species and 
probed immunoprecipitated Rpb1 for ubiquitin (Figure 8C, cim3-1). In contrast to WT cells 
we could not detect ubiquitylated Rpb1 species even after UV light treatment. This could 
result from very low immunoprecipitation efficiency of Rpb1 in cim3-1 cells (Figure 8C, 
compare middle panel of WT with cim3-1 cells).  
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Figure 8: Rpb1 degradation is dependent on the proteasome and the segregase Cdc48. 
(A) Rpb1 protein levels in WT and the proteasome mutant cim3-1 after UV light treatment (400 J/m2). Cells 
were shifted to 37°C for 1 hour before UV light irradiation and for the recovery phase in YPD medium. Rpb1 
was detected using the S2P-specific antibody. Dpm1 served as loading control. 
(B) Rpb1 protein levels in WT, cdc48-6 and cdc48-3 cells after UV light treatment (400 J/m2). Cells were 
shifted to 37°C for 1 hour before UV light irradiation and for the recovery phase in YPD medium. Rpb1 was 
detected using the S2P-specific antibody. Dpm1 served as loading control. 
(C) WT, cdc48-6 and cim3-1 cells were shifted to 37°C for 1 hour before being either UV light-irradiated (+) or 
not (-). Rpb1 was immunoprecipitated (Rpb1-IP) with the antibody S2P and ubiquitylated species of Rpb1 
were detected using a ubiquitin-specific antibody. Sepharose beads without addition of the Rpb1 antibody 
served as background-binding control (ctrl.). 
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4.3 Rpb1 ubiquitylation upon DNA damage involves the ubiquitin ligases 
Rsp5 and Elc1-Cul3  
To address which enzymes are crucial for the observed ubiquitin modification of Rpb1 
after DNA damage treatment, we tested the ubiquitin ligases Rsp5 and the Elc1-Cul3 
ligase complex (Cul3-Roc1-Elc1-Ela1) that were previously described to mediate Rpb1 
degradation107. 
First, we compared Rpb1 ubiquitylation in WT cells with cells expressing a mutant 
allele of RSP5 (Figure 9A, hypomorphic mutant rsp5-1). As seen before, Rpb1 
ubiquitylation was induced following UV light treatment in WT cells, but was completely 
absent in cells expressing a mutant allele of RSP5 (Figure 9A, left panels). Additionally, 
we used cells deficient in RSP5 (∆rsp5 cells) to exclude indirect effects from the 
hypomorphic mutant rsp5-1. As reported previously156, ∆rsp5 cells are unviable but can be 
rescued by addition of oleic acid to the medium or overexpression of OLE1, a fatty acid 
desaturase and crucial target of Rsp5-mediated regulation. Following Rpb1 ubiquitylation 
in WT and ∆rsp5 cells after UV light treatment, we confirmed previous results that cells 
deficient in RSP5 are unable to ubiquitylate Rpb1103,104 (Figure 9A).  
Next, we analyzed the second ubiquitin ligase described to act on Rpb1110,111. 
Three components of the Elc1-Cul3 ligase complex can be deleted, without influencing 
cell viability. We used cells deficient in the subunits Elongin C, Elongin A or Cullin 3 
(Figure 9B, ∆elc1, ∆ela1, ∆cul3) and probed for Rpb1 ubiquitylation by western blotting. 
Again, we could detect ubiquitylation of Rpb1 in WT cells, which was induced after UV 
light treatment. However, deletion of any component of the Elc1-Cul3 ligase complex 
abolished specifically the UV light-induced Rpb1 ubiquitylation (Figure 9B).  
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Figure 9: Rpb1 is ubiquitylated upon DNA damage involving the ubiquitin ligases Rsp5 and Elc1-Cul3. 
(A) UV light-irradiated (+) and non-irradiated (-) WT, rsp5-1 and ∆rsp5 (∆rsp5 YCplac111pADH1-OLE1) cells 
were lysed and Rpb1 was immunoprecipitated (Rpb1-IP) with antibody S2P. Ubiquitylated species of Rpb1 
were detected with the P4D1 antibody. Sepharose beads without addition of the Rpb1 antibody served as 
background-binding control (ctrl.). Previous to UV light treatment, rsp5-1 and the corresponding WT cells were 
shifted to 37°C.  
(B) Same procedure as described in (A) for WT, ∆elc1, ∆ela1 and ∆cul3 cells.  
 
 
Given that the two previously identified ubiquitin ligases were not only described to 
be important for DNA damage-induced Rpb1 ubiquitylation but also for promoting Rpb1 
degradation, we followed Rpb1 protein decay after UV light treatment in WT and cells 
deficient for Rsp5 or the Elc1-Cul3 ligase complex. Surprisingly, we detected turnover of 
Rpb1 in all tested cells of the previously described ubiquitin ligases similar to WT cells 
(Figure 10). Again, Rpb1 turnover was better detectable with the S2P-specific antibody 
compared to a whole pool RNAPII antibody (Figure 10A, compare 4H8 and S2P).  
Hence, although the ubiquitin ligase Rsp5 and the Elc1-Cul3 ligase complex 
indeed contribute to Rpb1 ubiquitylation as described previously, they do not seem to be 
crucial for proteasomal degradation of Rpb1.  
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Figure 10: Rpb1 monoubiquitylation by Rsp5 or the Elc1-Cul3 complex does not trigger Rpb1 
degradation upon DNA damage. 
(A) Rpb1 protein levels in WT, ∆elc1, ∆ela1 and ∆cul3 cells after UV light treatment (400 J/m2) followed by a 
recovery phase of 4 hours in YPD medium. Rpb1 was detected with the 4H8 or S2P-specific antibody. Dpm1 
served as loading control. 
(B) Rpb1 protein levels in WT, rsp5-1 and ∆rsp5 (∆rsp5 YCplac111pADH1-OLE1) cells after UV light 
treatment (400 J/m2). Previous to UV light treatment and for the recovery phase, rsp5-1 and the corresponding 
WT cells were shifted to 37°C. Rpb1 was detected using the S2P-specific antibody. Dpm1 served as loading 
control. 
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4.4 Rpb1 is SUMOylated upon DNA damage and thereby marked for 
degradation 
Because the previously described ubiquitin ligases are not implicated in Rpb1 
degradation we were wondering by which pathway elongating Rpb1 is degraded. In our 
degradation assays we consistently observed a slower migrating band, which was cross-
reactive with the S2P-specific antibody as well as with the whole pool Rpb1 antibodies 
(exemplified in Figure 10A). This slower migrating band appeared especially at early time 
points after recovery from DNA damage treatment. Since Rpb1 was not only described 
before to be ubiquitylated but also modified by SUMO72, we first wanted to confirm this 
observation. Indeed, we could detect Rpb1 species cross-reactive with a SUMO-specific 
antibody, especially after UV light irradiation (Figure 11A). Furthermore, in a hypomorphic 
mutant of the SUMO-conjugating gene UBC9 (ubc9ts cells), SUMOylation of Rpb1 was 
lost. Similarly, cells deleted either for the SUMO ligase gene SIZ1 or SIZ2, showed 
reduced SUMOylation of Rpb1, with SIZ1 having the major impact on Rpb1 SUMOylation.  
Next, we asked whether the slower migrating band detected in our turnover assays 
corresponded to SUMOylated Rpb1. To this end, we expressed SUMO as a protein fusion 
with GFP to generate a larger form (GFP-SUMO), which resulted indeed in an upshift of 
the slower migrating band (Figure 11B). Moreover, in this Rpb1 degradation assay we 
observed that the amount of SUMOylated Rpb1 peaked roughly 1 hour after recovery from 
UV light treatment and dropped gradually during the recovery process.  
Given that Rpb1 SUMOylation can be induced by DNA damage, and more 
interestingly, that we observed a decay of SUMOylated Rpb1 species following recovery 
from DNA damage, we asked whether SUMOylation influences Rpb1 degradation. To 
address this possibility, we compared UV light-induced Rpb1 decay in WT and mutant 
cells of the SUMO pathway. Strikingly, Rpb1 decay was almost abolished in cells 
defective in Ubc9 and Siz1 activity (Figure 11C and 11D), enzymes that were previously 
shown to perform Rpb1 SUMOylation (Figure 11A). In line with this finding, the slower 
migrating band in our decay assays, which corresponded to SUMOylated Rpb1, was not 
detectable in Ubc9- or Siz1-deficient cells. This finding provides first evidence that 
SUMOylation rather than ubiquitylation is the crucial initial modification needed for the 
observed degradation of elongating Rpb1.  
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Figure 11: DNA damage-induced SUMOylation of elongating Rpb1 triggers proteasomal degradation. 
(A) Western blot analysis of immunoprecipitated Rpb1 (Rpb1-IP) using the S2P-specific antibody from WT, 
ubc9, ∆siz1, ∆siz2 and ∆siz1 ∆siz2 cells. Cells were shifted to 37°C before treatment with (+) or without (–) UV 
light. SUMOylated Rpb1 species were detected with a SUMO-specific antibody. Sepharose beads without 
addition of the S2P-specific antibody served as background-binding control (ctrl.). 
(B) Rpb1 protein levels in WT and in mutant cells expressing GFP-tagged SUMO (under the ADH1 promoter) 
after UV light treatment (400 J/m2) following recovery in YPD medium. Rpb1 was detected with the S2P-
specific antibody. Dpm1 served as loading control.  
(C) Same experimental setup as in (A). WT and ubc9 cells were shifted to 37°C for 1 hour before UV light 
irradiation. (D) Same experimental setup as in (A) with WT, ∆siz1, ∆siz2 and ∆siz1 ∆siz2 cells. 
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4.5 Rpb1 SUMOylation is not restricted to previously identified lysine 
residues 
To study the function of protein SUMOylation or ubiquitylation, modification has to be 
abolished by either depletion of the corresponding enzymes or, more directly, by changing 
the codons for the targeted lysine (K) residues to an arginine (R) codon. Several lysines 
within Rpb1 have been described to be crucial for modification by SUMO or ubiquitin72,112. 
Since SUMOylation triggers Rpb1 degradation, we wondered whether mutation of 
previously identified SUMOylation sites (K217 and K1487) or even ubiquitylation sites 
(K330 and K695) had an impact on Rpb1 stability. We therefore expressed different 
mutant variants of Rpb1, with the specific lysine residues mutated to arginine, and tested 
first whether these mutant variants could be targeted for SUMOylation or ubiquitylation.  
However, the immunoprecipitated Rpb1 mutant variants were still reactive with 
SUMO- or ubiquitin-specific antibodies comparable to the corresponding WT control 
(Figure 12A). Thus, as it is already described for other substrates, also in the case of 
Rpb1 the SUMO- and ubiquitin-machinery seem to target several lysine residues for 
modification, and mutation of one lysine residue does not abolish Rpb1 SUMOylation or 
ubiquitylation. In line with this finding, changing the codons for previously identified 
SUMOylation sites to arginine codons (K217R and K1487R) did not abolish DNA damage-
induced degradation of Rpb1 (Figure 12B). 
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Figure 12: Rpb1 SUMOylation is not restricted to previously identified lysine residues. 
(A) Rpb1 was expressed in ∆rpb1 cells under its endogenous promoter as a WT version or the mutant 
versions K217R, K1487R (previously identified SUMOylation sites) and K330R, K695R (previously identified 
ubiquitylation sites). Cells were either UV light-irradiated (+) or not irradiated (–), lysed and Rpb1 was 
immunoprecipitated using the S2P-specific antibody. First, SUMOylated Rpb1 species were detected with an 
anti-SUMO antibody. The PVDF membrane was cleared from the anti-SUMO antibody and ubiquitylated 
species of Rpb1 were detected with an anti-Ub antibody (P4D1). Sepharose beads without addition of the 
S2P-specific antibody served as background-binding control (ctrl.). 
(B) Western blot analysis of Rpb1 protein levels in mutant versions K217R, K1487R of Rpb1 and the 
corresponding WT cells, treated with UV light and recovered in YPD medium. Rpb1 was detected with the 
anti-S2P antibody. Dpm1 served as loading control. 
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4.6 Degradation of Rpb1 is mediated by a SUMO-dependent pathway 
involving the SUMO-targeted ubiquitin ligase Slx5/Slx8 
Because of the finding that Rpb1 is SUMOylated upon DNA damage and is targeted for 
proteasomal degradation we assumed that this degradation pathway might involve the 
SUMO-targeted ubiquitin ligases (STUbLs). Indeed, Rpb1 decay after UV light treatment 
was abolished when we used mutant cells deficient in the heterodimeric yeast STUbL 
Slx5/Slx8. Moreover, the slower migrating species, which corresponded to SUMOylated 
Rpb1, accumulated significantly in this mutant background (Figure 13A).  
 
 
 
 
Figure 13: The SUMO-targeted ubiquitin ligase (STUbL) Slx5/Slx8 is involved in Rpb1 degradation. 
(A) Rpb1 protein levels in WT and ∆slx5 ∆slx8 cells after UV light treatment (400 J/m2) followed by a recovery 
time course in YPD medium over 4 hours. Rpb1 was detected with the anti-S2P antibody. Dpm1 levels served 
as loading control.  
(B) Denaturing Ni-NTA pulldown (Ni-PD) was performed to isolate His-SUMO conjugates from UV light-treated 
(400 J/m2) WT and ∆slx5 ∆slx8 cells following recovery in YPD medium. SUMOylated species of Rpb1 were 
detected with the S2P-specific antibody or the whole pool Rpb1 antibody 8WG16. SUMOylated Pgk1 served 
as pulldown control.  
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To confirm this finding, we enriched SUMOylated proteins using denaturing His-
SUMO Ni-NTA pulldown assays157. SUMOylated proteins from WT and STUbL-deficient 
cells before UV light treatment and after different recovery time points were probed with 
the Rpb1 elongation-specific antibody (S2P) or a whole pool antibody (8WG16) (Figure 
13B). In line with our previous findings, SUMOylated species of Rpb1 peaked especially 
one hour after UV light treatment and dropped gradually during the recovery phase in WT 
cells. However, degradation of SUMOylated Rpb1 species was significantly delayed in 
Slx5/Slx8-deficient cells (Figure 13B). Notably, we could observe that specifically 
SUMOylated Rpb1 species were subjected for degradation by Slx5/Slx8, independent of 
the antibody used for Rpb1 detection (Figure 13B, compare S2P and 8WG16).  
 
 
4.7 The kinases CTDK1 and Bur1/Bur2 are not degraded upon DNA 
damage 
In most of our degradation assays we used the S2P-specific antibody in order to detect 
specifically the elongating pool of Rpb1. To substantiate the idea that the observed decay 
of Rpb1 is indeed protein turnover, we thought to address alternative explanations for the 
observed decay of the signal through DNA damage-induced dephosphorylation of Rpb1. 
One possible scenario would be DNA damage-induced proteasomal degradation of the 
kinases that mediate serine 2 phosphorylation. In that hypothetical case, the CTD of Rpb1 
would not longer be phosphorylated at serine 2, resulting in a loss of the S2P signal in our 
analysis. We thus tested whether the stability of both kinases, CTDK1 and Bur1, is 
affected by UV light treatment.  
 First, we expressed epitope-tagged versions of all subunits of the CTDK1 complex 
as well as of Bur1 and its cyclin Bur2. This allowed us to follow protein levels after UV light 
treatment using an antibody against the epitope tag (HA), since commercial antibodies are 
not available for all kinase subunits. Interestingly, while most of the subunits were stable 
upon DNA damage, only HA-tagged versions of the subunits Ctk1 and Bur1 were unstable 
following recovery from DNA damage (Figure 14A and 14B). To exclude that the epitope 
tag interferes with protein function and causes artificial instability we additionally used 
antibodies against endogenous Ctk1 or Bur1 and followed protein levels in WT cells 
(Figure 14C and 14D).  
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Figure 14: The kinase complex CTDK1 and Bur1 or Bur2 are not targeted for degradation.  
(A) Cells with HA-tagged ctk1, ctk2 or ctk3 were UV light-treated (400 J/m2) followed by a recovery time 
course in YPD medium over 4 hours. Rpb1 levels were detected with an anti-S2P antibody. Ctk1, Ctk2 and 
Ctk3 levels were detected with an anti-HA antibody in the corresponding cells. Dpm1 levels served as loading 
control. 
(B) Cells with HA-tagged bur1 and bur2 were UV light-treated (400 J/m2) followed by a recovery time course in 
YPD medium over 4 hours. Rpb1 levels were detected with the anti-S2P antibody. Bur1 and Bur2 levels were 
detected with an anti-HA antibody in the corresponding cells. Dpm1 levels served as loading control. 
(C/D) WT cells were UV light-treated (400 J/m2), followed by a recovery time course in YPD medium over 4 
hours. Rpb1 protein levels were detected with the S2P-specific antibody. Ctk1 and Bur1 were detected with an 
anti-Ctk1 and anti-Bur1 antibody. Dpm1 levels served as loading control. 
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Strikingly, endogenous levels of Ctk1 and Bur1 were stable after UV light treatment, 
whereas Rpb1 levels dropped. This suggests that a C-terminal HA-fusion of Ctk1 and 
Bur1 cause protein instability. Most importantly, the stability of the endogenous proteins 
confirms that Rpb1 decay after DNA damage is not connected to serine 2 kinase levels.  
 
4.8 Transcription-coupled repair (TCR) is important for DNA damage-
induced Rpb1 degradation 
Stalled RNA polymerases activate mainly the transcription-coupled repair (TCR) branch, 
which was shown to influence Rpb1 degradation in mammalian cells118. To investigate 
whether TCR influences Rpb1 degradation also in yeast, we compared UV light-induced 
Rpb1 decay in WT and mutant cells defective in two branches of TCR (∆rad26, ∆rpb9). 
 
 
 
 
Figure 15: Transcription-coupled repair is important for DNA damage-induced Rpb1 degradation. 
(A/B/C) Rpb1 levels in WT, ∆rad26, ∆rpb9, and ∆rad16 cells after UV light treatment (400 J/m2) followed by a 
recovery time course in YPD medium over 4 hours. Rpb1 was detected with the anti-S2P antibody. Dpm1 
levels served as loading control.  
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Indeed, cells deficient in the DNA-dependent remodeler Rad26 or the non-essential 
RNAPII subunit Rpb9 where unable to degrade Rpb1 (Figure 15A and 15B). As a control, 
mutant cells defective in the global-genome (GG) NER branch (∆rad16) showed Rpb1 
decay indistinguishable from WT cells (Figure 15C). Interestingly, Rpb1 was SUMOylated 
in TCR-deficient cells, as the slower migrating band is still detectable. Thus, a stalled 
RNAPII complex likely recruits enzymes of the TCR pathway via SUMOylated Rpb1. 
However, how enzymes of the TCR pathway trigger subsequent Rpb1 degradation is still 
not known so far. 
 
 
4.9 RNAPII accumulates on chromatin after DNA damage if Rpb1 is not 
removed by proteasomal degradation 
According to our model, stalled RNAPII is cleared from damaged DNA by a SUMO-
dependent pathway, which involves active TCR not only for DNA lesion removal but also 
for the Rpb1 degradation mechanism itself. Previous work showed that cells deficient in 
TCR (∆rad26) show higher chromatin occupancy of RNAPII after DNA damage 
induction125. Following this work, we next asked whether RNAPII also accumulates on 
chromatin when we abolish Rpb1 SUMOylation and consequently SUMO-dependent 
Rpb1 degradation. Therefore, we performed chromatin immunoprecipitation (ChIP) 
studies after UV light treatment and measured Rpb1 levels at two different regions of the 
highly transcribed RPB2 gene. In line with previous work and our degradation analysis, 
Rpb1 levels on chromatin dropped over time following recovery from UV light treatment 
(Figure 16A and 16B). By contrast, Rpb1 signals persisted and even rose over time in 
∆siz1 as well as in ∆rad26 cells, arguing for a direct involvement in the turnover process of 
stalled RNAPII. This effect was much stronger for a region in close proximity to the 
transcriptional start site (TSS) (Figure 16A and 16D; RPB2-Region1) compared to a 
region further downstream (Figure 16B and 16D, RPB2-Region2). Moreover, when we 
monitored Rpb1 occupancy on the ACT1 gene at a region further downstream of the TSS 
(Figure 16C and 16D), Rpb1 signals dropped in WT cells following exposure to UV light 
but to a lower extent in ∆siz1 and ∆rad26 mutant cells (Figure 16C). From these data we 
interpret that RNAPII accumulates on chromatin upon DNA damage induction if Rpb1 is 
not SUMOylated and subsequently removed from the stalled complex. Moreover, Rad26 
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is indeed necessary to promote Rpb1 removal from chromatin. However, accumulation of 
RNAPII seems to be biased towards regions in close proximity to the TSS. To further 
analyze this phenomenon, a genome-wide Rpb1-ChIP approach would be best suited.  
 
 
 
 
Figure 16: RNAPII occupancy on chromatin after DNA damage. 
(A/B/C) Chromatin immunoprecipitation (ChIP) studies in different regions of the RPB2 locus and at the ACT1 
locus. Cells were irradiated with UV light (100 J/m2) and incubated for different repair times as indicated. Rpb1 
was immunoprecipitated with 8WG16 antibody or control IgG2a, followed by quantitative PCR amplification 
using primers for the RPB2 locus in WT, ∆siz1 and ∆rad26 cells. The values given for all tested regions are 
calculated by normalizing the ChIP-PCR signal with the IgG2a PCR signal and input PCR signal. 
(D) Schematic overview of primer sets used for the ChIP analysis within the RPB2 or ACT1 locus. Numbers 
correspond to nucleotides of the open reading frame.  
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4.10 Interference with the nuclear pore complex influences Rpb1 
degradation 
Degradation of Rpb1 critically depends on SUMOylation, which recruits the heterodimeric 
STUbL Slx5/Slx8 and presumably also factors of the TCR pathway. It has been suggested 
that a large fraction of the Slx5/Slx8 protein pool co-localizes with the nuclear pore 
complex (NPC) and especially binds the nuclear pore protein Nup84137. Nup84 and 
Slx5/Slx8 were previously described to be important to tether damaged DNA to the 
nuclear periphery for DNA repair. We thus wondered whether Rpb1 degradation would be 
mediated in proximity of nuclear pores.  
When we performed Rpb1 decay analysis in Nup84-deficient cells (∆nup84) we 
observed no Rpb1 degradation (Figure 17A). Surprisingly, we also found that 
SUMOylation of Rpb1 was absent in Nup84-deficient cells. Moreover, we were unable to 
detect SUMOylated Rpb1 after UV light treatment in these cells (Figure 17B). 
Interestingly, overall protein SUMOylation was not affected in Nup84-deficient cells 
(Figure 17B, compare input levels). However, in Nup84-deficient cells, not only the 
organization of the NPC is affected, but also the localization of Ulp1, a SUMO protease 
important for SUMO maturation at the nuclear pore79,158. Ulp1 mislocalization was also 
observed in cells deficient for the nuclear basket proteins Mlp1 and Mlp2. Strikingly, Rpb1 
degradation was also abolished in ∆mlp1 ∆mlp2 cells (Figure 17C), possibly because 
Rpb1 SUMOylation is impaired as well. From these preliminary experiments we speculate 
that interference with the NPC causes an impairment of Rpb1 SUMOylation and thereby 
leads indirectly to Rpb1 stabilization after DNA damage. 
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Figure 17: Interference with the nuclear pore complex abolishes Rpb1 SUMOylation and degradation.  
(A/B) Rpb1 protein levels in WT and ∆nup84 or ∆mlp1 ∆mlp2 cells after UV light treatment (400 J/m2) followed 
by a recovery time course in YPD medium over 4 hours. Rpb1 was detected with the anti-S2P antibody. Dpm1 
levels served as loading control.  
(C) UV light-irradiated (+) and not irradiated (-) WT, ∆nup84, ∆slx5 and ∆slx8 cells were lysed and Rpb1 was 
immunoprecipitated (Rpb1-IP) with antibody S2P. SUMOylated species of Rpb1 were detected with a self-
made anti-SUMO antibody. 
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5 Discussion 
The previously described mechanism for RNA polymerase II (RNAPII) removal from the 
DNA upon prolonged stalling implicates many factors, which were discovered over a long 
period and finally combined in one complex unifying model107,124. However, most studies 
did not distinguish between the chromatin-engaged or -unengaged pools of RNAPII, 
because antibodies recognizing potentially all forms of Rpb1 were used in these studies. 
These data might be difficult to interpret because various degradation pathways might act 
on different pools of Rpb1, which even can take place simultaneously. Although previous 
groups reported53 that the chromatin-engaged elongating pool of RNAPII is affected by 
stalling and therefore only this pool should be removed from the DNA by proteasomal 
degradation, in this study we used for the first time different antibodies against Rpb1. This 
enables us to distinguish between transcriptional initiating and elongating RNAPII. In this 
study we describe a different pathway for the removal of stalled RNA polymerase II from 
DNA. This stepwise mechanism involves initial Rpb1 SUMOylation followed by 
ubiquitylation by a SUMO-targeted ubiquitin ligase (STUbL) and subsequent proteasomal 
degradation.  
 
 
5.1 Potential loss of Rpb1 phosphorylation after DNA damage  
In this study the identification of new players in the Rpb1 degradation pathway was 
possible by using the S2P-specific Rpb1 antibody, which was described to recognize 
carboxy-terminal domain (CTD) repeats with phosphorylated serine 2. However, Rpb1 
decay after DNA damage treatment might also be interpreted as phosphorylation loss of 
Rpb1 CTD. This is unlikely to be the case for the following reasons: First, we and others 
showed that the known kinases CTDK1 and Bur1, responsible for serine 2 
phosphorylation, are not degraded upon DNA damage induction159. Nevertheless, a so far 
uncharacterized kinase might act on the CTD of Rpb1 upon DNA damage. However, this 
hypothetical kinase then must be activated and at the same time degraded upon DNA 
damage, which appears unlikely.  
 Second and even more speculative, the phosphatase Fcp1, which 
dephosphorylates the CTD at serine 2, might get activated upon DNA damage. In this 
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speculative model DNA damage would trigger degradation of a hypothetical Fcp1 inhibitor. 
However, such an inhibitor of Fcp1 has so far not been described. 
 On the contrary, our ChIP or His-SUMO pulldown data strongly support our 
interpretation that the observed Rpb1 decay is indeed degradation of the elongating form 
of Rpb1. In the ChIP experiments we observed that Rpb1 accumulates on the chromatin if 
the SUMOylation system is impaired, which is in line with our decay analysis. Moreover, in 
our His-SUMO pulldown experiments we found that specifically the SUMOylated from of 
Rpb1 is targeted for degradation independent of the antibody used for Rpb1 detection.  
 
 
5.2 Rpb1 is degraded in a SUMOylation- and ubiquitylation-dependent 
manner 
It is well established that Rpb1 is SUMOylated specifically upon DNA damage treatment, 
but the purpose of this modification remained so far enigmatic72. The biochemical data 
presented in this study allow us to propose a stepwise model, by which Rpb1 is first 
SUMOylated and subsequently ubiquitylated to trigger proteasomal degradation (Figure 
18). The elongating RNAPII complex is forced to stall at DNA lesion sites, which triggers 
recruitment of the SUMO-conjugating enzyme Ubc9 and the SUMO ligases Siz1 and Siz2. 
Consequently, the catalytic subunit of RNAPII, Rpb1, is SUMOylated upon DNA damage 
treatment72. How the SUMO machinery recognizes a prolonged stalled RNAPII complex 
is, however, unknown. It is established that Siz1 and Siz2 localize to DNA via their SAP 
domain and act e.g. on proteins linked to DNA repair77. For instance, several proteins 
involved in the NER pathway were shown to be SUMOylated after UV light treatment by 
Siz1 or Siz278,160. Interestingly, UV light treatment can either induce de novo SUMOylation 
of several NER factors or increase the SUMOylation pattern of others. Among them are 
the RNAPII subunits Rpb1 and Rpb4, which are already SUMOylated even in untreated 
cells78,160. However, UV light-induced SUMOylation of Rpb1 and potentially other RNAPII 
subunits might recruit DNA repair factors via SUMO-SIM interactions. In turn, these repair 
factors would also be SUMOylated to foster protein-protein interactions and create a DNA 
damage repair hot spot78.  
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Figure 18: Model of SUMO-dependent degradation of Rpb1. 
RNA polymerase II stalls at DNA lesion sites and is recognized by the remodeler Rad26 and subsequently 
targeted by the SUMO machinery. Rpb1 is SUMOylated (S) by the SUMO-conjugating enzyme Ubc9 together 
with the SUMO ligases Siz1 and Siz2 at potentially several lysine residues. SUMOylated Rpb1 recruits the 
SUMO-targeted ubiquitin ligase Slx5/Slx8 for subsequent polyubiquitylation. Slx5/Slx8 either extends the 
SUMO-chain with ubiquitin (Ub) entities or targets another lysine within Rpb1. Polyubiquitylated (and 
SUMOylated) Rpb1 is targeted by Cdc48 likely for extraction from the RNAPII complex and for delivery to the 
proteasome. Rpb1 is also targeted by the previous identified ubiquitin ligases Rsp5 and Elc1-Cul3 for 
monoubiquitylation, but the function is unknown so far.  
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Moreover, whether SUMOylated Rpb1 is further targeted for degradation might 
depend on the ability of the recruited repair machinery to remove the DNA damage in the 
context of a stalled RNAPII49,161. Only if this is not possible, DNA has to be cleared from 
the stalled RNAPII complex to make the DNA lesion accessible for repair. In that case, we 
assume that the STUbL Slx5/Slx8 is recruited to these damaged sites to target Rpb1 and 
potentially also other proteins for polyubiquitylation. Since we were not able to detect a 
direct binding between Rpb1 and Slx5/Slx8, this interaction could be very transient or 
might occur upon Rpb1 SUMOylation. From our His-SUMO pulldown experiment we know 
that Slx5/Slx8 preferentially targets SUMOylated Rpb1 for ubiquitylation, which in turn 
triggers degradation. Moreover, Slx5/Slx8 might attach ubiquitin entities to the preexisted 
SUMO-chain162 or to other lysine residues within Rpb1 (Figure 18).  
Our finding that Slx5/Slx8 is involved in Rpb1 ubiquitylation and degradation 
reveals striking parallels to other DNA damage repair pathways. Persistent DNA breaks 
and collapsed replication forks are targeted to the nuclear periphery in a Slx5/Slx8-
dependent manner137,163-165. Thus, Slx5/Slx8 associates with nuclear pore proteins like 
Nup84. Although in most cases the targeted substrates are still unknown, it was 
suggested that Slx5/Slx8 targets SUMOylated proteins for ubiquitylation to trigger 
proteasomal degradation thereby facilitating DNA damage repair137,138,165. In line with this, 
also Rpb1 degradation is dependent on an intact nuclear pore complex. 
 
 
5.3 Influence of the nuclear pore complex on Rpb1 degradation 
In this study we showed that UV light-induced SUMOylation of Rpb1 was abolished in 
cells deficient in the nuclear pore proteins Nup84 or Mlp1 and Mlp2. As a consequence, 
DNA damage-induced degradation of Rpb1 was inhibited. This might be due to the 
following reasons: First, the SUMO-specific protease Ulp1 is located at the nuclear 
periphery where it functions in SUMO maturation. Deletion of the nuclear basket proteins 
Nup84 or Mlp1/Mlp2 leads to Ulp1 mislocalization and consequently might interfere with 
SUMO maturation and the SUMO metabolism158,166. However, although UV light-induced 
Rpb1 SUMOylation was abolished, overall protein SUMOylation was not affected, arguing 
against a limited SUMO pool. Moreover, if Ulp1 is not tethered to the NPC, it could also 
deSUMOylate Rpb1. So far it is unclear whether Rpb1 is in general a substrate of SUMO 
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proteases after DNA damage treatment. Our initial results showed that Rpb1 SUMOylation 
is not enriched in mutants of the SUMO protease Ulp1 or Ulp2 (data not shown). 
However, further experiments are necessary to elucidate whether a mislocalization of Ulp1 
leads to Rpb1 deSUMOylation.  
Second, interference with the NPC leads not only to mislocalization of Ulp1 but 
also of Slx5/Slx8101,164. As described for other potential substrates, recognition of 
SUMOylated Rpb1 by Slx5/Slx8 is important for subsequent ubiquitylation and 
degradation. Whether the catalytic activity of Slx5/Slx8 relies on the localization to the 
NPC is still unknown. A separation-of-function protein variant of Slx5/Slx8, which cannot 
localize to the NPC but displays ubiquitylation function would help to investigate whether 
localization to the NPC is important for Rpb1 SUMOylation and subsequent degradation.  
Finally, SUMOylation and degradation of Rpb1 might occur in close proximity to 
the NPC. Considering that gene transcription occurs in the vicinity of the NPC to facilitate 
the coordination between mRNA maturation and export167,168, degradation of a stalled 
RNAPII at the nuclear pore represents an attractive hypothesis.  
 
 
5.4 Rpb1 is monoubiquitylated by previously identified ubiquitin ligases 
During this study we could confirm that Rpb1 is indeed a target of the ubiquitin ligases 
Rsp5 and Elc1-Cul3107. However, deletion of the corresponding genes did not abolish 
degradation of the elongating form of Rpb1 after DNA damage. Moreover, when we 
performed Rpb1 immunoprecipitation assays only the monoubiquitylated form of Rpb1 
was detectable, and both ubiquitin ligases seem to contribute to this modification. Since 
Rpb1 is highly regulated by posttranslational modifications during transcription, 
monoubiquitylation of Rpb1 performed by Rsp5 and Elc1-Cul3 might be important to 
control other cellular activities. 
 Rsp5 was recently implicated in the clearance of misfolded proteins from the 
cytoplasm upon heat-shock induction169. Since RSP5 deletion is lethal156, most studies to 
analyze Rpb1 decay were performed with temperature-sensitive mutants105,107. In these 
mutants, Rsp5 function is diminished at elevated temperatures. Consequently, shifts to a 
higher temperature would induced protein misfolding and trigger the Rsp5-dependent 
clearance pathway. Also Rpb1 with its highly repetitive and unstructured CTD might have 
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a high propensity for misfolding and could be targeted by Rsp5 for protein quality control. 
Interestingly, our initial data revealed that Rpb1 is also monoubiquitylated after heat-shock 
treatment in an Rsp5-dependent manner (data not shown). It would be interesting to see 
whether specifically the cytosolic pool of Rpb1 is targeted for Rsp5-dependent 
ubiquitylation and degradation upon heat-shock.  
 Moreover, ubiquitylation of Rpb1 by Rsp5 is dependent on binding to the CTD of 
Rpb1103,106. By doing so Rsp5 competes for binding with the isomerase Ess1. Both 
enzymes were shown to bind to Rpb1’s CTD via their WW-domain and thereby 
presumably regulate RNAPII levels available for transcription104,170. It was proposed that 
binding of Ess1 to the CTD enhances transcription whereas Rsp5 binding counteracts 
somehow this effect perhaps through Rpb1 degradation. Since Rsp5 localizes primarily to 
the cytosol, it was suggested that Rpb1 would be exported from the nucleus and targeted 
for ubiquitylation and degradation in the cytoplasm. From our data, we know that 
ubiquitylation of Rpb1 by Rsp5 upon UV light or heat-shock treatment does not lead to 
degradation of the elongating pool. Potentially this modification might block re-import of 
RNAPII to the nucleus, thereby counteracting transcription until DNA repair is finished. 
Furthermore, we could not abolish Rpb1 monoubiquitylation by interfering with the 
previously described ubiquitylation sites K330 or K695112. However, so far we cannot 
exclude that a mutant variant of Rpb1, in which both lysines are replaced by arginines, 
would abolish UV light-induced Rpb1 monoubiquitylation. An alternative explanation is that 
these sites are prone for modification after DNA damage-induction by other means than 
UV light. Moreover, K695 is located in a region were Rpb9, a non-essential subunit of 
RNAPII, binds113. Ubiquitylation at this site could be used to control Rpb9 binding and 
thereby its function.  
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5.5 Role of Rad26 in RNAPII removal from chromatin upon DNA damage 
The transcription-coupled repair (TCR) factor Rad26 and its human homolog Cockayne 
syndrome (CS) protein B were previously described to act on stalled RNAPII. It is 
assumed that Rad26 and CSB are recruited to and travel with the elongating RNAPII, but 
how these factors recognize a stalled RNAPII complexes is unknown40,41. CSB, but 
apparently not Rad26, harbors a ubiquitin-binding domain (UBD) at the CTD, which is 
important for its function in the TCR pathway38. However, potential binding substrates to 
this domain are unknown so far. Moreover, comparable to Rpb1, CSB itself was shown to 
be ubiquitylated and targeted by Cdc48 for proteasomal degradation at the end of the 
TCR process122,126. Interestingly, instead of a UBD, Rad26 possesses several putative 
SUMO-interacting motifs (SIMs), which might be crucial for binding to SUMOylated Rpb1. 
Initial results suggest that mutation of SIMs at least at the very C-terminus of Rad26 does 
not impair Rpb1 degradation (data not shown). Moreover, in contrast to CSB, no direct 
interaction between Rad26 and Rpb1 was reported so far38,171. This indicates that binding 
of Rad26 to the RNAPII complex might also be delivered through other subunits. 
Additionally, since Rad26/CSB belongs to the SWI2/SNF2 chromatin remodeling protein 
family, its potential function in chromatin remodeling does not necessarily require robust 
binding to Rpb1. Rather, Rad26/CSB might facilitate Rpb1 removal through chromatin 
remodeling, thereby increasing lesion accessibility to enhance TCR49,172. Interestingly, the 
chromatin remodeling complex INO80 was recently implicated in Rpb1 removal117. This 
suggests that although transcription occurs on nucleosome-free DNA, chromatin 
remodeling indeed facilitates Rpb1 degradation. 
 Moreover, while CSB promotes Rpb1 degradation, Rad26 was reported to have a 
protective effect121. This is in conflict with our results and results obtained by others125,173. 
We demonstrated that Rad26 function in a similar way as its human homolog, as RAD26 
deletion abolished specifically degradation of the elongating pool of Rpb1. These 
conflicting results might originate from the choice of antibodies used to follow Rpb1 
degradation. Additionally, we and others found that deletion of Rad26 results in an 
accumulation of Rpb1 at chromatin, likely because the TCR pathway is blocked and 
degradation of Rpb1 is impaired125.  
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5.6 Parallels of Rpb1 modification and degradation to other SUMO- and 
STUbL-dependent pathways 
Targeting DNA damage-stalled RNAPII complexes for SUMOylation and subsequent 
proteasomal degradation through the action of the SUMO-targeted ubiquitin ligase 
(STUbL) seems to be another example how genome stability is preserved by ubiquitin and 
ubiquitin-like proteins.  
Comparable to transcriptional stalling, also a stalled replication fork is controlled by 
the action of ubiquitin and the small ubiquitin-like modifier (SUMO). Modification of Rpb1 
might resemble the complex modification pattern of PCNA, in which the two different 
modifiers control translesion synthesis, error-free DNA damage repair and inhibition of 
unwanted recombination13,16,174. Moreover, stalled replication forks are targeted to the 
nuclear periphery in a Slx5/Slx8-dependent manner for DNA repair137. Although the target 
substrate of Slx5/Slx8 at the stalled replication fork is so far uncharacterized, various other 
DNA-bound proteins were shown to be targeted by a two-step mechanism, implicating first 
SUMOylation followed by ubiquitylation and degradation to regulate and facilitate DNA 
damage repair133,138,175.  
 Such a two-step mechanism resulting in SUMOylated and ubiquitylated substrates 
represents an elegant mode of action to recruit proteins containing ubiquitin-and/or 
SUMO-interacting motifs. For instance, the segregase Cdc48 together with its co-factor 
Ufd1 was shown to target both ubiquitylated and SUMOylated proteins and, more 
strikingly, also STUbL substrates153,154. Cdc48 extracts proteins from their cellular 
environment and facilitates their deubiquitylation or degradation by the proteasome. Also 
in the case of Rpb1, SUMOylation might first recruit repair factors and Slx5/Slx8. 
Subsequently, Cdc48 is recruited to SUMOylated and ubiquitylated Rpb1 and helps to 
segregate it from the chromatin-bound RNAPII complex for proteasomal degradation, as 
described previously115.  
Taken together, the mechanism for Rpb1 degradation upon DNA damage, 
described in this study, is distinctly different from the previously described107. However, 
our new degradation model is supported by several lines of evidence and involves a 
similar set of factors, which are also implicated in removal of other chromatin-bound 
proteins. Moreover, this study expands the substrate spectra of the SUMO-targeted 
ubiquitin ligase Slx5/Slx8 by Rpb1 and helps to elucidate their mode of action. 
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6 Materials and Methods 
6.1 Microbiological Techniques 
If not otherwise indicated, all chemicals and reagents were obtained from Applied 
Biosystems, BD, Biomol, Bio-Rad, Enzo, GE Healthcare, Greiner Bio-One, Life, Merck, 
Millipore, New England Biolabs, Peqlab, Pierce, Promega, Roche, Roth, Serva, Sigma 
and Thermo Scientific. Enzymes and deoxynucleotide triphosphates (dNTPs) for 
molecular biology were purchased from NEB. DNA oligonucleotides for cloning were 
custom-made by Eurofins MWG. For all procedures described, sterile flasks, sterile and 
de-ionized water as well as sterile solutions were used. Microbiological, molecular 
biological and biochemical techniques described below were derived from standard 
protocols176. 
 
 
6.1.1 Escherichia coli (E. coli) Techniques 
 
E. coli Strains  
 
Strain Genotype Reference 
XL1-Blue hsd R17 rec A1 end A1 gyrA46 thi-1 sup E44 relA1 lac 
[F' pro AB lacIqZΔ M15 Tn10 (Tetr)] 
Stratagene 
 
 
E. coli Media 
 
LB-medium/plates:  1% Trypton (Difco) 
     0.5% yeast extract (Difco) 
     1% NaCl 
     1.5% agar - for plates 
     sterilized by autoclaving  
 
For plasmid selection 100 μg/ml ampicillin or 30 μg/ml kanamycin were added. 
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Preparation of competent E. coli cells 
LB medium was inoculated with a single colony and grown at 37°C with constantly 
shaking to produce an overnight culture. The main culture was inoculated with an OD600 of 
0.05 and 1 L was harvested at an OD600 of 0.5 by centrifugation (15 min, 4000 g, 4°C). All 
further steps were performed at 4°C with pre-chilled solutions. The pellet was washed with 
250 ml and afterwards with 125 ml of 10% glycerol. The pellet was resuspended in 2 ml of 
10% glycerol. Aliquots were frozen on dry ice and stored at -80°C.  
 
Transformation of plasmid DNA into competent E. coli cells 
For transformation of expression vectors into E. coli electroporation was used. Competent 
cells were thawed on ice and 50 µl were mixed with either 10 ng plasmid DNA or half of a 
ligation mixture. The cell/DNA suspension was electroporated in a pre-chilled cuvette (0.1 
cm gap) with a pulse of 1.8 kV at a resistance of 200 Ω using a GenePulser Xcell 
electroporater. The mixture was plated onto selective medium.  
  
 
6.1.2 Saccharomyces cerevisiae (S. cerevisiae) Techniques 
 
S. cerevisiae Strains  
 
Strain Genotype Reference 
W303 leu2-3,112 ade2-1 can1-100 his3-11,15 ura3-1 
trp1-1 RAD5 
Jentsch strain collection 
BY4741 ura3∆0 leu2∆0 his3∆1 met15 ∆0 177 
DF5 his3∆200 leu2-3,11 lys2-801 trp1-1 ura3-52 178 
Y0933 RC757 Mat alpha, his6 met1 sst2-1 cyh2 can1 Jentsch strain collection 
Y0934 RH448 Mat a, leu2 his4 lys2 ura3 bar1 Jentsch strain collection 
YIH516 DF5 elc1::hphNT1 This study 
MJK110 DF5 ela1::hphNT1 This study 
MJK108 DF5 cul3::hphNT1 This study 
Y2240 DF5 rsp5::HIS3 YCplac111-pADH1-OLE1 Jentsch strain collection 
FW1808 his4-912 ΔR5, lys2-128Δ, ura3-52, rsp5-1 106  
Y0554 DF5 cim3-1, ura3-52, leu2Δ1 179 
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Y0649 DF5 cdc48-6 154 
Y3784 DF5 cdc48-3 Jentsch strain collection 
MJK369 DF5 pADH-GFP-Smt3::natNT2 Jentsch strain collection 
Y0174 DF5 ubc9Δ::TRP1 leu2::ubc9Pro-Ser::LEU2 180 
Y1558 DF5 siz1::HIS3MX6 J. Stingele 
Y3619 DF5 siz2::HIS3MX4 J. Stingele 
YJS DF5 siz1::HIS3MX6 siz2::HIS3MX4 J. Stingele 
YIH443 DF5 slx5::HIS3MX6 slx8::hphNT1 This study 
MJK116 DF5 rpb1::hphNT1 YCplac111-rpb1::LEU Jentsch strain collection 
MJK117 DF5 rpb1::hphNT1 YCplac111-rpb1K330R::LEU Jentsch strain collection 
MJK151 DF5 rpb1::hphNT1 YCplac111-rpb1K217R::LEU Jentsch strain collection 
MJK155 DF5 rpb1::hphNT1 YCplac111-rpb1K1487R::LEU Jentsch strain collection 
YIH607 DF5 rpb1::hphNT1 YCplac111-rpb1K695R::LEU This study 
YIH590 DF5 YIplac211-pADH-His-Smt3-tADH::URA3 F. Paasch 
YIH599 DF5 slx5::natNT2 slx8::hphNT1 YIplac211-pADH-
His-Smt3-tADH::URA3  
This study 
YIH677 DF5 rad26::kanMX4 This study 
YIH475 DF5 rpb9::natNT2 This study 
YIH363 DF5 rad16::hphNT1 This study 
MJK619 DF5 nup84::kanMX6 M. Kern 
YIH465 DF5 mlp1::hphNT1 mlp2::natNT2 This study 
YIH543  DF5 ctk1-6HA::kanMX4 This study 
YIH545 DF5 ctk2-6HA::kanMX4 This study 
YIH547 DF5 ctk3-6HA::kanMX4 This study 
YIH549 DF5 bur1-6HA::kanMX4 This study 
YIH551 DF5 bur2-6HA::kanMX4 This study 
 
 
S. cerevisiae Vectors 
 
Name Type Reference 
YCplac111 Integrative 181 
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S. cerevisiae Plasmids 
 
Name Plasmid Reference 
pMJK44 YCplac111rpb1 M. Kern 
pIH31 YCplac111rpb1K695R::LEU This study 
pMJK62 YCplac111-rpb1K217R::LEU M. Kern 
pMJK63 YCplac111-rpb1K1487R::LEU M. Kern 
pMJK46 YCplac111rpb1K330R::LEU M. Kern 
 
 
S. cerevisiae Media and Solutions 
 
YPD medium/plates:    1% yeast extract 
2% bacto-peptone 
2% glucose 
2% agar (only for plates) 
sterilized by autoclaving 
 
YPD G418/NAT/Hph Plates:  after autoclaving, YPD medium containing 2% agar 
was cooled to 50°C before addition of 200 mg/L 
G418 (geneticine disulfate; Sigma), 100 mg/L NAT 
(noursethricin, HKI Jena) or 500 mg/L Hph 
(hygromycin B, PAA Laboratories)  
 
SC medium/plates:  0.67% yeast extract 
0.2% amino acid drop-out mix  
2% glucose 
2% agar (only for plates) 
sterilized by autoclaving 
 
Amino acid drop-out mix: 20 mg Ade, Ura, Trp, His 
30 mg Arg, Tyr, Leu, Lys 
50 mg Phe 
100 mg Glu, Asp 
150 mg Val 
200 mg Thr 
400 mg Ser 
 
Sporulation medium:  2% (w/v) KAc  
sterilized by autoclaving 
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SORB Buffer:     100 mM LiOAc 
10 mM Tris-HCl, pH 8.0 
1 mM EDTA, pH 8.0 
1 M sorbitol 
sterilized by filtration 
 
PEG Solution:    100 mM LiOAc 
10 mM Tris-HCl, pH 8.0 
1 mM EDTA, pH 8.0 
40% (w/v) PEG-3350 
sterilized by filtration 
stored at 4 °C 
 
Zymolyase 100T solution:   0.9 M sorbitol 
0.1 M Tris-HCl, pH 8.0 
0.2 M EDTA, pH 8.0 
50 mM DTT 
0.5 mg/ml Zymolyase 100T 
 
 
 
Cultivation and storage of S. cerevisiae cells 
Yeast cells were either cultivated on agar plates or in liquid cultures. For growth on agar 
plates cells were streaked from a glycerol stock using a sterile toothpick or a glass pipette. 
For a liquid culture 5-25 ml of YPD were inoculated with typically one single colony from a 
freshly streaked agar plate and grown overnight. The main culture was inoculated from the 
overnight culture to an OD600 of 0.1-0.2 in baffled flasks (size ≥ 3x liquid culture volume). 
The cultures were grown to mid-log phase (OD600 of 0.6-1) under constantly shaking on a 
shaking platform (150-200 rpm). The optical density was determined using a photometer, 
whereby OD600 of 1 corresponds to approximately 1.5 x 107 cells/ml. Cultures and plates 
were incubated at 30°C for growth.  
  Agar plates and overnight cultures of temperature-sensitive cells were incubated at 
the permissive temperature of 25°C. The main culture was grown at 30°C (semi-
permissive temperature) to an OD600 of 0.6-0.8 and switched to 37°C (non-permissive 
temperature) for at least 1 hour. Agar plates were sealed with parafilm for short-term 
storage (1-2 weeks) at 4°C. For long-term storage at -80°C, glycerol stocks were prepared 
by freezing cells from stationary phase (OD600 ≥ 3) in 15% glycerol.  
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Preparation of competent S. cerevisiae cells 
Cells from a mid-log phase culture (50 ml of OD600 of 0.6-1) were harvested by 
centrifugation (5 min, 500 g) and washed once with 25 ml of cold sterile water and 
afterwards with 10 ml of cold SORB buffer. The pellet was resuspended in 360 µl of SORB 
buffer and 40 µl carrier DNA (denatured salmon or herring sperm DNA, 10 mg/ml 
Invitrogen). Aliquots of 55 µl of competent cells were stored at -80°C.  
 
Transformation of DNA into competent S. cerevisiae cells 
For transformation, 0.2 µg of a circular plasmid or 2 µg of a linearized plasmid or PCR 
product were mixed with either 10 µl or 50 µl of competent yeast cells and incubated in 6 
volumes of PEG buffer at room temperature. After 30 min, DMSO was added to a final 
concentration of 10% and the reaction was incubated at 42°C for 12 min (heat-shock). In 
case of temperature-sensitive strains the heat-shock was reduced to 8 min. Afterwards, 
the cells were centrifuged (2 min, 380 g) and resuspended in 100 µl of sterile water and 
plated onto SC selection plates. In case of G418 (kanMX6), hygromycin (hphNT1) or 
nourseothricin (natNT2) resistance, the pellet was resuspended in 2 ml of YPD and 
incubated at 25°C for at least 1 hour while shaking before plating on SC selection plates. 
Plates were incubated at 25°C for 2-3 days and replica plated to eliminate false-positive 
colonies.  
 
Genetic manipulation of S. cerevisiae cells 
A PCR-based method was used to construct strains with epitope tagged genes or gene 
deletions182,183. In Brief, a PCR product was generated using selection cassettes, which 
harbors either only a selection marker (deletion) or selection marker and epitope 
sequence and is flanked by genomic targeting sequences. After transformation into 
competent yeast cells, the PCR product was integrated into the genome by homologous 
recombination. Correct integration of the PCR product was analyzed by colony PCR 
(section 6.2.4). Epitope-tagged proteins were additionally tested by western blot analysis.  
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Mating type analysis of haploid yeast strains 
The yeast tester strains RC634 (Mat a) and RC75-7 (Mat α), which are hypersensitive to 
the pheromone secreted by yeast of the opposite mating type, were used for mating type 
identification of haploid strains. Therefore, several colonies of a freshly streaked tester 
strain were resuspended in 2 ml sterile water and mixed with 100 ml of 1% agar (1% w/v 
water, pre-cooled to 50°C). Pre-warmed YPD plates were covered with 7 ml of the cell-
agar suspension and allowed to dry. For analysis, strains were replica-plated or streaked 
on the tester plates and incubated at 30°C overnight. Growth of the tester strain is 
inhibited by a strain of the opposing mating type, which results in a free region around the 
streaked strain.  
 
Mating, sporulation and tetrad analysis  
One colony of freshly streaked yeast strains of the opposite mating type were 
resuspended in 100 µl water and plated on pre-warmed YPD plates. After incubation 
overnight at 30°C, cells were analyzed for selection markers (if available) or for diploid 
cells. For sporulation, 300 µl of an overnight culture of the selected diploid cells was 
washed three times with cold water and once with sporulation medium. The final pellet 
was resuspended in 3 ml of sporulation medium and grown at 25°C for at least 3 days in a 
culture tube while shaking. The sporulated diploid cells were incubated 1:1 with 
Zymolyase 100T solution for 8 min at room temperature. Tetrad dissection was performed 
with a micromanipulator (Singer MSM Systems) on YPD plates. After incubation for 2-4 
days at 25°C, the mating type and genotype was analyzed by replica plating on mating 
tester and selection plates, respectively.  
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6.2 Molecular Biological Techniques  
6.2.1 General Buffers and Solutions 
 
TE buffer    10 mM Tris/HCl, pH 8.0 
1 mM EDTA 
 
TBE buffer (5x)   90 mM Tris 
90 mM boric acid 
2.5 mM EDTA, pH 8.0 
 
DNA loading dye (6x)  0.5% SDS 
0.25% (w/v) bromophenol blue 
0.25% glycerol 
25 mM EDTA, pH 8.0 
 
 
6.2.2 Purification of DNA  
Isolation of plasmid DNA from E. coli 
A 5 ml LB overnight culture was used to isolate plasmid DNA using a commercial 
available kit (AccuPrep Plasmid Mini Extraction Kit, Bioneer). Purification was performed 
closely to the manufacturers instruction. 
 
Isolation of genomic DNA from S. cerevisiae 
Genomic DNA was isolated from an overnight culture or from colonies of a freshly 
streaked plate using a commercial available kit (Master Pure Yeast DNA Purification Kit, 
Epicentre). Purification was performed as described in the manufacturers instruction. 
 
Determination of DNA concentration 
DNA concentrations were determined photometrically using a NanoDrop ND-1000 
spectrophotometer (PeqLab). Thereby, the absorbance was measured at a wavelength of 
260nm. An OD260 of 1 corresponds to a concentration of 50 µg/ml of double stranded 
DNA.  
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6.2.3 Molecular Cloning 
Digestion of DNA with restriction enzymes 
Restriction enzymes from New England Biolabs were used according to manufacturers 
instruction. Typically 2 µg of DNA was digested in a 30-40 µl reaction at 37°C for 2 hours 
or overnight. To avoid re-ligation of plasmid DNA the 5’-end was dephosphorylated by 
incubation of the reaction with 1 µl calf intestinal phosphatase (CIP, New England Biolabs) 
at 37°C for 1 hour. 
 
Separation of DNA by agarose gel electrophoresis 
Sample DNA was mixed with 6x loading dye and loaded on a 0.8% agarose gel, 
containing 0.5 µg/ml ethidium bromide. Electroporesis was performed at 120 V in TBE 
buffer. DNA was visualized with a UV transilluminator (324 nm). The size was estimated 
by comparison with a 1 kb DNA ladder marker (Invitrogen).  
 
Purification of DNA fragments from agarose gels 
The band of interest was excised from the agarose gel using a sterile razor blade. The 
DNA was purified using a commercial available kit (QIAquick Gel Extraction Kit, Qiagen). 
Purification was performed as described in the manufacturers instruction. 
 
Ligation of DNA fragments 
The digested and dephosphorylated plasmid was incubated with the digested DNA insert 
together with T4 DNA ligase (New England Biolab) in a 20 µl reaction for 20 min at 25°C. 
The ration between plasmid and insert was 1:3 (Insert = (bp Insert / bp plasmid) x 300 ng). 
Afterwards the T4 DNA ligase was heat inactivated by incubation at 65°C for 10 min. Prior 
to transformation in electrocompetent E. coli cells, the reaction was dialyzed against 
deionized water on a nitrocellulose filter (pore size 0.05 µm, Millipore) for 10min.  
 
DNA sequencing 
DNA sequencing was performed by MWG Eurofins. A 17 µl reaction containing 15 µl 
purified DNA (50 ng/µl plasmid DNA, 1-10 ng/µl PCR product) together with 2 µl 
sequencing primer (10 µM) was send to Eurofins. 
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6.2.4 Polymerase Chain Reaction (PCR) 
For amplification of DNA fragments from genomic DNA, targeting cassettes for gene 
deletion or epitope tagging or to test for genomic recombination events PCR was used. 
Oligonucleotides (primers) were designed and purchased from MWG Eurofins. Reactions 
were prepared on ice and carried out in a Veriti® Thermal Cycler (Thermo Fischer). 
 
Amplification of genomic DNA fragments 
The PhusionTM DNA polymerase was used for DNA fragment amplification from genomic 
DNA.
 
Reaction Mix µl 
5x HF buffer 
dNTP Mix (10 mM each) 
template gen. DNA (200ng/µl) 
Primer1 
Primer2 
H2O 
PhusionTM DNA Polymerase  
10 
1 
1 
3 
3 
31.5 
0.5 
 
 
 
Thermocycler  
98°C 1 min 1x 
98°C 
60°C 
72°C 
20 sec 
20 sec 
40 sec/1kb 
 
25x 
72°C 10 min 1x 
4°C ∞ 1x 
Amplification of targeting cassettes 
For gene deletions the plasmids pFA6a-natNT2, pFA6a-hphNT1 or pFA6a-HIS3MX6 were 
used. According to the epitope tag different pYM plasmids were used as templates182,183. 
The PCR product was analyzed by gel electrophoresis, purified from the agarose gel and 
further used for transformation in competent yeast cells.  
 
Reaction Mix µl 
10x Thermo Pol Buffer 
dNTP Mix (10 mM each) 
cassette plasmid (100 µg/ml) 
Primer1 
Primer2 
H2O 
Vent DNA Polymerase 
Taq DNA Polymerase 
10 
3 
1 
3 
3 
74.5 
2.1 
2.4 
 
 
Thermocycler  
95°C 5 min 1x 
95°C 
54°C 
68°C 
30 sec 
30 sec 
2 min 40 sec 
 
10x 
95°C 
54°C 
68°C 
30 sec 
30 sec 
2 min 40 sec + 
20 s/cycle 
 
20x 
68°C 5 min 1x 
4°C ∞  
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PCR screening of genomic recombination events (Colony PCR) 
To confirm whether a PCR product was integrated into the correct chromosomal location, 
a PCR based strategy was used. Therefore, one colony was resuspended in 20 µl of 0.02 
M NaOH, glass beads were added (425-600 nm, Sigma) and the mixture was boiled for 5 
min at 99°C. From the supernatant 1.6 µl were used as template for the PCR reaction. 
 
 
Reaction Mix µl 
10x Thermo Pol Buffer 
dNTP Mix (10 mM each) 
template mixture 
Primer1 
Primer2 
H2O 
Taq DNA Polymerase 
2 
0.7 
1.6 
1.3 
1.3 
12.9 
0.2 
 
Thermocycler  
94°C 5 min 1x 
94°C 
55°C 
72°C 
30 sec 
30 sec 
1 min 
 
30x 
72°C 5 min 1x 
4°C ∞  
 
 
 
6.3 Biochemical Techniques  
6.3.1 General Buffers and Solutions  
 
PBS    10 mM phosphate, pH 7.4 
137 mM NaCl 
2.7 mM KCl 
 
HU sample buffer   200 mM Tris, pH 6.8 
8 M urea 
5% (w/v) SDS 
1 mM EDTA 
1.5% (w/v) DTT 
0.1% (w/v) bromophenol blue 
 
2x Lämmli buffer  125 mM Tris/HCl, pH 6.8 
4% SDS 
20% glycerol 
0.01% bromophenol blue 
2.5% β-ME 
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MOPS running buffer   50 mM MOPS 
50 mM Tris 
3.5 mM SDS 
1 mM EDTA 
 
Blotting buffer    5% (v/v) 20x SWIFTTM Western buffer 
10% (v/v) methanol 
 
TBS-T    25 mM Tris/HCl pH 7.5 
137 mM NaCl 
2.6 mM KCl 
0.1% Tween 20 
 
 
6.3.2 Protein Methods 
DNA damage treatment of yeast cells 
DNA damage was induced by UV-C light or 4-nitroquinoline 1-oxide (4NQO) treatment. 
For UV light treatment cells were grown to mid-log phase (OD600 of 0.8-1) and 30-50 
OD600 were harvested by centrifugation (5 min, 500 g) in a 50 ml Falcon tube. The pellet 
was washed once with 40 ml PBS buffer and the final pellet was resuspended in 40 ml 
PBS buffer. UV light irradiation was performed in 140-mm culture dishes with a dose of 
400 J/m2 (BS04-irradiation chamber, Dr. Gröbel UV-Elektronik GmbH) in the dark. The cell 
suspension was collected in a dark 50 ml Falcon tube and centrifuged 5 min at 500 g. For 
recovery from the UV light treatment the cell pellet was resuspended in 30 ml YPD and 
incubated for 4 h at 30°C or 37°C while shaking. Every hour a sample of 0.8 OD600 cells 
was harvested, pelleted, frozen in liquid nitrogen and stored at -80°C. For Rpb1 decay 
analysis the pellet was lysed by TCA-precipitation and analyzed by western blot. 
  For 4NQO treatment, cells were grown to mid-log phase (OD600 of 0.8-1) and 
4NQO was added (10 µg/ml in DMSO). For Rpb1 decay analysis samples were harvested 
and treated as described above.  
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Preparation of denatured protein extracts (TCA-precipitation) 
Small-scale cell amounts were lysed under denaturing conditions. Usually pellets (0.8-1 
OD600) were incubated in 150 µl of lysis buffer (1.85 M NaOH, 7.5% ß-mercaptoethanol) 
for 15 min on ice. After addition of 150 µl of 55% (w/v) trichloroacetic acid (TCA), the 
reaction was incubated a second time for 15 min on ice. The precipitated material was 
collected by sequential centrifugation (30 min/10 min, 18.000 g, 4°C). After removal of the 
supernatant, the pellet was resuspended in 40 µl HU-buffer and analyzed by western blot. 
 
Rpb1-Immunoprecipitation (Rpb1-IP) 
For immunoprecipitation about 50 OD600 cells were resuspended in 800 µl lysis buffer 
(lysis buffer: 50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% TritonX-100, 0.1% 
Na-Deoxycholate, 10 mM NEM, complete protease inhibitors) and lyzed with a bead-
beater (MM301, Retsch) using zirconia/silica beads (BioSpec Inc.). To shear the DNA and 
release protein bound to it, lysates were transferred to hard plastic Sumilon 15 ml 
centrifuge tubes (Sumitomo Bakelite Co.) by piggyback elution and the volume was 
adjusted to 1 ml with lysis buffer. Sonication (water/ice bath sonication: Bioruptor UCD-
200, Diagenode) was performed with 10 times 30 sec cycles (with 30 sec breaks in 
between) and afterwards centrifuged at 18,000 g for 10 min. As an input sample 20 µl of 
the supernatant were boiled (95°C, 5 min) in 2x Lämmli buffer. For Immunoprecipitation 
500 µl of the extract were incubated with 4 µl of anti-Rpb1 antibodies (3E10) for 1.5 hour 
at 4°C on a rotation wheel followed by addition of 100 µl equilibrated Protein A Sepharose 
CL-4B 50/50 slurry (GE Healthcare) for 30 min. The beads were washed 3-times with lysis 
buffer and boiled (95°C, 5 min) in 30 µl 2x Lämmli buffer. Usually 10 µl of the supernatant 
were analyzed by western blot.  
 
Ni-NTA pulldown (Ni-PD) 
Ni-NTA PDs under denaturing conditions were performed under modified conditions as 
previously described157. 50OD600 of UV light-treated and -untreated cells were harvested, 
washed with water, pelleted by centrifugation, frozen in liquid nitrogen, and stored for 
some days at -80°C. 
  The frozen pellet was resuspended in cold lysis buffer (lysis buffer: 1.85 M NaOH, 
7.5% β‐mercaptoethanol) to a final volume of 6 ml. After 15 min on ice, an equal volume 
of cold 55% TCA was added and kept on ice for another 15 min. Proteins were pelleted by 
centrifugation at 3500 g for 5 min (4°C), and the pellet was washed twice with cold water. 
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Subsequently, the pellet was thoroughly resuspended in 12 ml of Buffer A plus 0.05% 
Tween20 (Buffer A: 6 M guanidinium chloride, 100 mM NaH2PO4, 10 mM Tris; pH 
adjusted to pH 8.0 with NaOH). After transfer into centrifuge tubes, the suspensions were 
shaken for 1 hour at 180 rpm at room temperature for resolubilization. Insoluble material 
was removed by centrifugation (20 min, 4°C, 23.000 g), and the clear supernatant was 
transferred into a fresh tube. After adding imidazole to a final concentration of 20 mM, 200 
µl of Ni-NTA agarose slurry (Qiagen) was added to the tubes for the protein pull-down, 
and the sample was incubated on a rotating wheel at 4°C overnight. The material was 
then poured into a column, washed with 50 ml of Buffer A plus 0.05% Tween20, and 
subsequently with 50 ml of Buffer C plus 0.05% Tween20 (Buffer C: 8 M urea, 100 mM 
NaH2PO4, 10 mM Tris/HCl; pH adjusted to pH 6.3 with HCl). Proteins bound to the Ni‐NTA 
column were eluted with 1 ml of elution buffer (elution buffer: Buffer C, 0.05% Tween20, 
250 mM imidazole) into a 2 ml tube. Eluted proteins were precipitated by addition of 1 ml 
of 55% TCA, incubation for 10 min and centrifugation at 20.000 g for 30 min. The pellet 
was boiled in 30 µl HU-Buffer for 10 min at 65°C. Samples were analyzed by western blot.  
 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins were separated using pre-cast 4-12% gradient NuPAGE Bis-Tris polyacrylamide 
gels (Invitrogen). Electrophoresis was performed in cold MOPS running buffer at 120 V for 
10 min followed by 200 V for 1-1.5 hours under cooling conditions. Protein size was 
estimated by comparison with the Precision Plus Protein All Blue Standard (Bio-Rad) 
molecular weight marker.  
 
Immuno-blot analysis (western blot) 
Proteins separated by SDS-PAGE were transferred to a polyvinylidene fluoride membrane 
(Immobilion-P, Millipore). Therefore, the membrane was activated in 100% methanol for 
1min. The transfer was performed in cold SWIFT blotting buffer at 80 V for 2 hours at 4°C 
using a wet tank system (GE Healthcare). Afterwards, the membrane was blocked for 20 
min with 5% skim milk powder dissolved in TBS-T. Incubation with the primary antibody 
(dissolved in TBS-T, 5% skim milk powder, 0.02% NaN3) was performed overnight at 4°C. 
The membrane was washed 3 times with 10 ml TBS-T before incubated with HRP-
coupled secondary antibody (dissolved in TBS-T, 5% skim milk powder) for 60 min. 
Unbound antibody was removed by 3 washing steps with 10 ml of TBS-T for 10 min. To 
detect the chemiluminescence signal the ECL, ECL-plus or ECL advanced kit (GE 
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Healthcare) was used. The membrane was incubated with the solutions as described by 
the manufacturers instruction and visualized by exposure to a chemiluminescence film 
(Amersham Hyperfilm ECL, GE Healthcare) or using a luminescent image analyzer (LAS-
3000, Fujifilm).  
  For sequential usage of the membrane, antibodies were removed from the 
membrane by incubation with 10 ml of RestoreTM PLUS western blot stripping buffer 
(Themo Scientific) for 15 min. The membrane was washed with 10 ml TBS-T for 5 min, 
blocked and incubation with a primary antibody, as described above.  
 
 
Primary Antibodies 
 
Specificity Type Reference 
anti-Rpb1 (3E10) rat, monoclonal Millipore 
anti-Rpb1 (8WG16) mouse, monoclonal Abcam 
anti-Rpb1 (4H8) mouse, monoclonal Cell Signaling 
anti-SUMO rabbit, polyclonal 16 
anti-Ub (P4D1) mouse, monoclonal Santa Cruz Biotechnology 
anti-Dpm1 mouse, monoclonal Life Technologies 
anti-Pgk1 mouse, monoclonal  Life Technologies 
anti-Ctk1 rabbit, polyclonal Abcam 
anti-Bur1 rabbit, polyclonal 184 
anti-HA mouse, monoclonal Santa Cruz Biotechnology 
 
 
Secondary Antibodies 
 
Specificity Type Reference 
anti-mouse  HRP-coupled IgG Dianova 
anti-rabbit  
anti-rat 
HRP-coupled IgG 
HRP-coupled IgG 
Dianova 
Dianova 
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6.3.3 Chromatin Methods 
Chromatin immunoprecipitation (ChIP) 
ChIP was performed as described previously185. Mid-log phase yeast cells were treated 
with or without UV light (100 J/m2) and allowed to repair for indicated time in the dark. 
Cells were cross-linked with 1% formaldehyde for 15 min and quenched with 125 mM 
glycin for at least 10 min. Cells were pelleted (5 min, 5000 g, 4°C) and washed once with 
cold TBS. The pellet was frozen in liquid nitrogen and stored for some days at -80°C.  
Cell lysis was performed in 800 µl lysis buffer (lysis buffer: 50 mM HEPES, pH 7.5, 
140 mM NaCl, 1 mM EDTA, 1% TritonX-100, 0.1% sodium deoxycholate, 1 mM PMSF, 
complete protease inhibitors) using zirconia/silica beads (BioSpec Inc.) in a multi-tube 
beat-beater (MM301, Retsch GmbH). The reaction was shaken 6 times for 3 min with a 
frequency of 30/s with 3 min cooling intervals. The supernatant was transferred to a hard 
plastic Sumilon 15 ml centrifuge tubes (Sumitomo Bakelite Co.) by piggyback elution and 
the volume was adjusted to 1 ml with lysis buffer. Sonication (water/ice bath sonication: 
Bioruptor UCD-200, Diagenode) was performed with 40 times 30 sec cycles (with 30 sec 
breaks in between) at an output of 200 W to shear the DNA to an average size of 250-500 
bp. Beat beating and sonication was performed in the cold room (4°C). The solution was 
transferred into a 2 ml tube, adjusted to 2 ml with lysis buffer and centrifuged (14.000 g, 
15 min). As an input sample 90 µl of the supernatant was stored at -80°C. For 
immunoprecipitation 900 µl of the supernatant were incubated either with 4 µl anti-Rpb1 
(8WG16, Abcam) antibody or with 2 µl IgG2a (Bethyl Laboratories, Inc.) overnight with 
head-over-tail rotation at 4°C. Equilibrated Protein A Sepharose CL-4B 50/50 slurry (GE 
Healthcare) was added (100 µl per sample) and incubated with head-over-tail rotation for 
1 hour at 4°C. The beads were washed once with lysis buffer, wash buffer 1 (wash buffer 
1: 50 mM HEPES, pH 7.5, 500 mM NaCl, 1 mM EDTA, 1% TritonX-100, 0.1% sodium 
deoxycholate, 1 mM PMSF), wash buffer 2 (wash buffer 2: 10 mM Tris/HCl, pH 8.0, 250 
mM LiCl, 0.5% NP-50, 0.5% sodium deoxycholate, 1 mM EDTA) and TE (Tris/HCl, pH 
8.0). The beads were resuspended in 100 µl TE containing 20 µg RNAse A and incubated 
for 30 min at 37°C. After removal of the RNAse A mixture from the beads, elution was 
performed with 500 µl elution buffer (1% SDS, 0.1 M NaHCO3) for 15 min with head-over-
tail rotation at room temperature. The supernatant was transferred to a new 1.5 ml tube. 
The input samples were thawn and mixed with 410 µl of elution buffer. To revert cross-
links, 20 µl of 5 M NaCl was added to IP and Input samples and incubated for at least 5 
hours at 65°C. To precipitate the DNA, 1 ml of 99% ethanol was added to the samples 
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and incubated at -20°C overnight. The mixture was centrifuged (14.000 g, 15 min) and the 
pellet was washed once with 70% ethanol. The dry pellet was resuspended in 100 µl TE 
buffer. Proteinase K digestion was performed for 30 min at 50°C. Input and ChIP samples 
were purified using the QIAquick PCR purification Kit (Qiagen). Samples were analyzed 
by RTq-PCR. 
 
 
Quantitative real-time PCR (RTqPCR) 
ChIP samples were analyzed by RT-qPCR using the 2x KAPA SYBR FAST qPCR Master 
Mix (PeqLab) and the LightCycler 480 System (Roche). Therefore, 2 µl of the ChIP 
sample (undiluted) or input sample (1:10 diluted) were mixed with 18 µl of Master Mix. For 
each sample triplicates in a 384-well LightCycler plate were tested. To determine the DNA 
concentration a dilution series for each primer pair was generated from the input sample 
(1:5, 1.50, 1:500, 1:5000) and used as a standard. DNA concentration was quantified from 
the LightCycler PCR amplification curves using the second derivate maximum. As a 
control for primer specificity a melting curve analysis was performed to determine whether 
only one PCR product was amplified.  
  For normalization the values for each strain and each time point were calculated 
by normalizing the ChIP-PCR signal with the IgG2a PCR signal and input PCR signal.	All 
data in Figure 16 are depicted as the mean ± SEM (standard error of the mean) of 3 
independent ChIP experiments.  
 
 
Reaction Mix µl 
2x KAPA SYBR FAST  
Primer1 (10 µM) 
Primer2 (10 µM) 
H2O 
ChIP sample 
10 
0.4 
0.4 
7.2 
2 
 
 
LightCycler  
95°C 3 min 1x 
95°C 
57°C 
72°C 
10 sec 
20 sec 
1 sec 
 
40x 
Melting curve analysis 
4°C ∞  
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Primers used for RTqPCR 
 
Name Sequence Gene Reference 
IH_268 for 
IH_269 rev 
IH_270 for 
IH_271 rev 
IH_274 for 
IH_275 rev 
ATGTCAGACCTTGCAAACTCAG 
TTCGGTAGTATGTTGAGCCA 
TCAAGTCAAGCTTTATGGTCGT 
AAGCATTTCCAGCATTTGCC 
CGTCGGTAGACCAAGACACC 
TCCCAGTTGGTGACAATACCG 
RPB2 
RPB2 
RPB2 
RPB2 
ACT1 
ACT1 
125 
125 
125 
125 
This study 
This study 
 
 
6.4 Computer-aided Analysis  
For literature review the National Centre for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov) and Papers3 (http://www.papersapp.com) were used. For 
sequence research the electronic database provided by the Saccharomyces Genome 
Database (www.yeastgenome.org) was used. The DNA-Star software (DNA Star Inc.) was 
used for DNA sequence analysis as well as for DNA restriction enzyme maps. The 
contrast for western blot images was adjusted linearly using Adobe Photoshop (Adobe 
Systems Inc.). Figures were designed and labeled using Adobe Power Point (Adobe 
Systems Inc.). ChIP data representation and statistics were done with GraphPad Prism 
(GraphPad Software, Inc.). The Microsoft Office software package (Microsoft Corp.) was 
used for text and table generation.  
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8 Abbreviations 
4-NQO  4-nitroquinoline 1-oxide 
aa  amino acid(s) 
AAA  ATPases associated with 
  various cellular activities 
Ac  acetate 
ADP  adenosine 5’-diphosphate 
AMP  adenosine 5’-  
  monophosphate 
ATM  ataxia telangiectasia mutated 
ATP  adenosine 5’-triphosphate 
ATR  ATM- and RAD3-related 
bp  base pair(s)  
°C  degree celcius 
Cdc  cell division cycle 
CDK  cyclin-dependent kinase 
cDNA  complementary DNA 
CENT2  centrin2 
ChIP  chromatin 
 immunoprecipitation 
CHX  cycloheximide 
CPD  cyclobutane pyrimidine dimer 
CS  Cockayne syndrome 
CTD  carboxy-terminal domain 
CTDK  CTD kinase 
Cul  cullin 
DMSO   dimethylsulfoxide 
DNA  deoxyribonucleic acid 
DUB  deubiquitylating enzyme 
DSB  DNA double-strand break 
DTT  dithiothreitol 
E  glutamic acid 
E. coli   Escherichia coli 
e.g.   exempli gratia, for example 
E1  activating enzyme 
E2  conjugating enzyme 
E3  ligase 
E4  chain elongating ligase 
EDTA  ethylenediaminetetraacidic  
acid 
Ela  elonginA 
Elc  elonginC 
ER  endoplasmic reticulum 
ERAD  ER-associated degradation 
ERCC1  excision repair cross- 
  complementation group 1 
G  glycine 
g  gram 
g  gravity 
G1  gap 1 phase of the cell cylce 
G418  geneticine disulfate 
Gal  galactose 
GFP  green fluorescent protein 
GGR  global genome repair 
Glu  glutamate 
h  hour(s) 
HA  hemagglutinin epitope 
HECT  homologous to the E6-AP 
  carboxyl terminus 
His  histidine 
HMGN  high mobility group  
  nucleosome binding domain 
Hph  hygromycin B 
hphNT1 gene conferring resistance to 
  hygromycin 
HRP  horse radish peroxidase 
I  isoleucine 
IgG  immunoglobulin G 
IP  immunoprecipitation 
K  lysine 
kanMX6 gene conferring resistance to 
  G418 
kb  kilo base pair(s) 
kDa  kilo Dalton 
Kin  kinase 
kV  kilo Volt 
L  liter(s) 
LB  Luria-Bertani 
Leu  leucine 
LMU   Ludwig-Maximilians- 
  University Munich 
Log  logarithmic 
m  milli (x10-3) 
µ  micro (x10-6) 
M  molar 
µm  micrometre(s) 
MAT  mating-type locus 
MATα  MAT locus containing α  
  information 
MATa  MAT locus containing a  
  information 
MCM  minichromosome  
  maintenance 
min  minute(s) 
MMS  methyl methanesulfonate  
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MPI  Max-Planck-Institute 
MRN  serine/threonine kinase  
  complex Mre11 Rad50 Nbs1 
mRNA  messenger ribonucleic acid 
MRX  serine/threonine kinase  
  complex Mre11 Rad50 Xrs2 
Myc  epitope from c-Myc 
n  nano (x10-9) 
NAT  nourseothricin 
natNT2  gene conferring resistance to 
 nourseothricin 
NEM  N-ethylmaleimide 
NER  nucleotide excision repair 
nm  nanometre(s)  
NFκB  nuclear factor κ-light-chain-
  enhancer of activated B cells 
NP-40  nonidet p-40 
ODx  optical density at x nm 
ORF  open reading frame 
Ω  Ohm 
PAGE   polyacrylamide gel  
  electrophoresis 
PBS  phosphate buffered saline 
PCNA  proliferating cell nuclear 
  antigen 
PCR  polymerase chain reaction 
PE  phosphatidylethanolamine 
PEG  polyethylene glycol 
Pgk1   phospho-glycerate kinase 1 
PML  promyelocytic leukaemia 
PPi  pyrophosphate 
Pol  polymerase 
Pro  proline 
PVDF  polyvinylidene fluoride 
R  arginine  
Rad  radiation 
RING  really interesting new gene 
RNA  ribonucleic acid 
RNAPII  RNA polymerase II 
ROS  reactive oxygen species 
RPA  replication protein A 
Rpb  RNA polymerase B 
rpm  rounds per minute 
RT-PCR real-time PCR 
S  Svedberg 
S. cerevisiae Saccharomyces cerevisiae 
Sc   synthetic complete 
SDS  sodium dodecyl sulfate 
sec  second(s) 
Ser  serine 
SH  thiol group 
SIM  SUMO-interaction motif 
Siz  SAP and Miz-finger domain 
Smt  suppressor of Mif2 
STUbL  SUMO-targeted ubiquitin 
  ligase 
Sub  substrate 
SUMO  small ubiquitin-like modifier 
Swi/Snf  switching defective/sucrose 
  non-fermentable 
TBE  tris, boric acid, EDTA 
TBS-T   tris-buffered saline-Tween20 
TCA  trichloro acidic acid 
TCR  transcription coupled repair 
TDD  trichothiodystrophy 
TE   Tris EDTA 
TFIIH  transcription factor II H 
TFIIS  transcription factor II S 
Thr  threonine  
TLS  translesion synthesis 
Tris   Tris(hydroxymethyl)- 
  aminomethane 
Trp  tryptophan 
Tyr  tyrosine 
Ub  ubiquitin 
Ubc  ubiquitin conjugating 
UBP  ubiquitin protease 
UBD  ubiquitin-binding domain 
UBL  ubiquitin-like 
Ufd  ubiquitin-fusion degradation 
Ulp  UbL-specific protease 
USP  ubiquitin-specific protease 
UTR  untranslated region 
UV  ultraviolet 
UV-DDB UV-damaged DNA-binding  
UVSSA  UV-stimulated scaffold A 
V  Volt 
v/v  volume per volume 
vs.  versus 
WB  western blot 
WCE  whole cell extract 
WT  wild-type 
w/v  weight per volume 
Wwp  WW domain protein 
XAB  XPA binding 
XP  xeroderma pigmentosum 
Y  tyrosine 
YPD  yeast bactopeptone dextrose 
β -Me  β-mercaptoethanol
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